{"study_id": 2088, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the antitumor mechanisms of Astragalus polysaccharides (APS) and their relationship with volatile organic compounds (VOCs) in exhaled breath, as well as the pharmacological enhancement of cisplatin by APS in lung cancer treatment.", "results_summary": "APS demonstrated anticancer properties and enhanced the antitumor efficacy of cisplatin, particularly at a high dosage (400 mg/kg). It also restored levels of 12 VOCs in exhaled breath, indicating potential for real-time monitoring of lung cancer treatment.", "population_specificity": "Lewis lung cancer (LLC) mice", "effective_dosage": "400 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:06.477305+00:00"}
{"study_id": 2090, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to uncover the mechanisms by which Astragalus mongholicus Polysaccharides (mAPS) alleviate diabetic nephropathy (DN) in rats.", "results_summary": "mAPS administration reduced fasting blood glucose, improved renal function markers, modulated oxidative stress and inflammation, and positively influenced gut microbiota in DN rats.", "population_specificity": "Rat model of diabetic nephropathy induced by high-sugar and high-fat diet with streptozotocin injection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:07.934248+00:00"}
{"study_id": 2089, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the clinical efficacy and potential pharmacological mechanisms of Astragalus and Salvia miltiorrhiza (AS) in treating diabetic nephropathy (DN).", "results_summary": "AS significantly improved clinical outcomes and renal function in DN patients, reduced fasting blood glucose levels when used for over 12 weeks, and interacted with key signaling pathways (PI3K/Akt, MAPK, NF-kappa B). In vivo experiments confirmed AS's ability to improve renal function, UACR, and iron metabolism biomarkers.", "population_specificity": "Patients with diabetic nephropathy (1,443 participants across 15 studies).", "effective_dosage": "Not specified", "study_duration": "Treatment duration varied, with notable effects observed beyond 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:08.477656+00:00"}
{"study_id": 2091, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus Polyphenols (ASP) could protect against doxorubicin-induced cardiotoxicity by reducing oxidative stress and preserving mitochondrial function via the PI3K/AKT/NRF2 pathway.", "results_summary": "ASP treatment reversed doxorubicin-induced reductions in cell viability and mitochondrial membrane potential, decreased reactive oxygen species levels, and downregulated cardiac injury markers ANP and BNP. The protective effects were mediated through activation of the PI3K/AKT/NRF2 pathway.", "population_specificity": "AC16 and H9C2 cardiomyocytes (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:10.987954+00:00"}
{"study_id": 2093, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a hydrogel loaded with Astragalus membranaceus-P. notoginseng extract (APCS) in promoting wound healing.", "results_summary": "The APCS hydrogel significantly accelerated wound healing in rats by enhancing fibroblast proliferation, reducing inflammation, promoting vascular and neuronal regeneration, and improving collagen formation and re-epithelialization.", "population_specificity": "SD rats with full-thickness skin wounds.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.515345+00:00"}
{"study_id": 2092, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (AP) could suppress microglial activation and oxidative stress in retinal ischemia-reperfusion (RIR) by promoting Sorcs2 and Lama1 expression.", "results_summary": "AP treatment reduced oxidative stress, increased Sorcs2 and Lama1 expression, and suppressed microglial activation in RIR models, suggesting therapeutic potential for inflammatory retinal damage.", "population_specificity": "Rat retinal samples and microglial cells (in vitro and in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:11.938089+00:00"}
{"study_id": 2094, "supplement_id": 897, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether a novel Astragalus extract (KFB) could function as a growth hormone alternative by promoting bone growth through IGF-1 upregulation.", "results_summary": "KFB increased GHRH and ghrelin mRNA levels, enhanced body weight and bone growth, and elevated IGF-1 and IGFBP-3 levels comparably to GH treatment, suggesting it may act as a GH-mimetic agent.", "population_specificity": "Sprague-Dawley rats and GT1-7 hypothalamic cell line.", "effective_dosage": "Various dosages (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:14.238651+00:00"}
{"study_id": 2095, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) could reduce EGFR inhibitor-induced cutaneous adverse reactions (EICAR) and restore immune balance when delivered via dissolvable microneedles.", "results_summary": "APS combined with minocycline or epidermal growth factor, delivered via microneedles, restored epidermal conditions and immune cell balance. APS also alleviated EICAR in non-treated areas, suggesting systemic effects.", "population_specificity": "Patients experiencing EGFR inhibitor-induced cutaneous adverse reactions (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:14.303902+00:00"}
{"study_id": 2096, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Astragalus polysaccharide (APS) and APS nanoparticles on testicular blood flow, semen quality, and reproductive hormone levels in Ossimi rams.", "results_summary": "The study found that both APS and APS nanoparticles improved testicular blood flow, semen quality, and increased serum testosterone, estradiol, nitric oxide, and total antioxidant capacity, with nanoparticles showing a more significant effect.", "population_specificity": "Sexually mature Ossimi rams", "effective_dosage": "2 g/ram/day (nano APS) and 20 g/ram/day (APS)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:14.543370+00:00"}
{"study_id": 2097, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the mechanisms by which Astragalus and Angelica sinensis exert anti-angiogenic effects to delay the progression of pulmonary nodules to lung cancer.", "results_summary": "The study found that Astragalus and Angelica sinensis possess anti-angiogenic properties, which help ameliorate hypoxia, restore blood composition, enhance vascular structure, and inhibit pro-angiogenic expressions, collectively delaying the transformation of pulmonary nodules to lung cancer.", "population_specificity": "Not specified (general focus on pulmonary nodules and lung cancer progression)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:15.601677+00:00"}
{"study_id": 2098, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the pharmacological effects and molecular mechanisms of Astragalus membranaceus (AM) in treating colorectal cancer, as well as its potential synergistic effects with conventional therapies.", "results_summary": "The study found that AM's active components, including polysaccharides, flavonoids, saponins, and nanovesicles, exhibit anti-cancer effects by inducing apoptosis, inhibiting tumor angiogenesis and metastasis, regulating the cell cycle and tumor microenvironment, and reversing drug resistance. AM also enhances the efficacy of chemotherapy, radiotherapy, targeted therapy, and surgery.", "population_specificity": "Colorectal cancer patients (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:16.942242+00:00"}
{"study_id": 2100, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic potential of an Astragalus mongholicus and Scutellaria baicalensis (AM-SB) mixture for treating ischemic stroke in mouse models.", "results_summary": "The AM-SB mixture reduced infarction volume, inflammation, and pyroptosis-related markers while improving motor and cognitive functions in ischemic stroke models. Early and sustained intervention showed significant benefits in behavioral assessments.", "population_specificity": "Transient middle cerebral artery occlusion (tMCAO) and photothrombotic (PTB) mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.009754+00:00"}
{"study_id": 2099, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify and confirm the pathogen causing root rot in Astragalus mongholicus and assess its impact on the plant.", "results_summary": "The study identified Rhizoctonia solani AG-5 as the causative agent of root rot in Astragalus mongholicus, confirmed through morphological, molecular, and pathogenicity tests. Symptoms in inoculated plants matched field observations, fulfilling Koch's postulates.", "population_specificity": "Astragalus mongholicus plants in a field in Weiyuan County, Gansu Province, China.", "effective_dosage": "Not applicable (pathogen inoculation study).", "study_duration": "60 days post-inoculation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:19.712599+00:00"}
{"study_id": 2101, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the neuroprotective properties of Astragalus mongholicus (AM) in acute ischemic stroke using in vitro and in vivo models.", "results_summary": "AM treatment significantly reduced ischemic damage, improved neurological outcomes, increased neuroprotective metabolites, reduced gliosis, and decreased oxidative stress in both acute and chronic stroke models.", "population_specificity": "Mouse models (photothrombotic and transient middle cerebral artery occlusion) and in vitro oxygen-glucose deprivation model using mouse neuroblastoma cells.", "effective_dosage": "Not specified", "study_duration": "Short-term (0-2 days) or long-term (0-27 days) post-stroke treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:20.711205+00:00"}
{"study_id": 2104, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Astragalus polysaccharide (APS) could mitigate skeletal muscle structure and function impairments induced by D-galactose in mice.", "results_summary": "APS administration improved grip strength, muscle fiber cross-sectional area, and mitochondrial health in D-gal-treated mice, while also enhancing autophagy-related protein expression (LC3II and PINK1).", "population_specificity": "Male C57BL/6J mice (8 weeks old, SPF grade)", "effective_dosage": "100 mg/kg APS by gavage", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:22.273535+00:00"}
{"study_id": 2103, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharides (APS) could alleviate high-fat diet-induced exacerbation of acute pancreatitis by modulating gut microbiota.", "results_summary": "APS reduced neutrophil infiltration, downregulated NF-\u03baB, suppressed necroptosis, and restored gut microbiota balance, increasing Lactobacillus reuteri and propionate levels, which collectively reduced pancreatitis severity.", "population_specificity": "Mice with high-fat diet-induced acute pancreatitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:22.835497+00:00"}
{"study_id": 2105, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how Astragalus polysaccharides (APS) regulate the Nrf2/SLC7A11/GPX4 signaling pathway to induce ferroptosis in ovarian cancer cells.", "results_summary": "APS effectively inhibited ovarian cancer cell activity and proliferation, increased markers of ferroptosis (L-ROS, MDA, Fe\u00b2\u207a), and reduced glutathione levels. It also downregulated Nrf2, SLC7A11, and GPX4 expression, with enhanced effects when combined with RSL3.", "population_specificity": "Ovarian cancer cells (Caov-3 and SKOV3 cell lines).", "effective_dosage": "Not specified.", "study_duration": "48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:23.969585+00:00"}
{"study_id": 2102, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of Astragalus membranaceus on neurological function in patients with acute aneurysmal subarachnoid hemorrhage (aSAH).", "results_summary": "Astragalus administration significantly improved neurological outcomes, with higher percentages of good GOS scores and Barthel index scores in the treatment group compared to the control group at two and four weeks post-intervention. The effects were more pronounced in patients with elevated baseline IL-6 levels.", "population_specificity": "88 patients with acute aneurysmal subarachnoid hemorrhage (aSAH).", "effective_dosage": "3 g orally, three times daily.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:24.195157+00:00"}
{"study_id": 2106, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-leukemic effects of Astragalus membranaceus (AM) and its components, focusing on their mechanisms of action in leukemia inhibition.", "results_summary": "The study found that AM and its compounds (Betulinic acid, Kaempferol, Hederagenin, formononetin, and Astragaloside-A) exhibited strong anti-leukemic effects by targeting FLI1, suppressing tryptophan-mediated Kyn production, and modulating immune responses. Astragaloside-A specifically inhibited leukemogenesis in vivo by targeting IDO1, TDO2, and HDC, leading to reduced inflammation and leukemia suppression.", "population_specificity": "Mouse model of erythroleukemia induced by Friend virus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:26.244676+00:00"}
{"study_id": 2107, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of Astragalus injection in treating viral myocarditis by comparing it to standard treatment.", "results_summary": "The study found that Astragalus injection significantly improved the effectiveness rate (92.79% vs. 77.71%) and reduced levels of cardiac biomarkers (AST, CK, CK-MB, LDH, cTnI) in patients with viral myocarditis.", "population_specificity": "Patients with viral myocarditis (2793 participants across 26 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.208455+00:00"}
{"study_id": 2108, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dietary Astragalus polysaccharides (APS) could enhance the efficacy of an inactivated vaccine against Pseudomonas plecoglossicida infection in large yellow croakers.", "results_summary": "Dietary APS combined with the vaccine improved survival rates, reduced bacterial load, enhanced antioxidant status, and strengthened immune responses (including innate and adaptive immunity) compared to the vaccine alone.", "population_specificity": "Large yellow croakers (Larimichthys crocea)", "effective_dosage": "Not specified", "study_duration": "14 days of APS feeding prior to vaccination", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:27.531014+00:00"}
{"study_id": 2109, "supplement_id": 897, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of EFT (a TCM-based regimen including Astragalus) on kidney function in stage 3-5 CKD patients and explore its potential mechanisms in protecting renal function.", "results_summary": "EFT significantly improved eGFR in CKD patients, enhanced HK-2 cell viability, reduced fibrosis-related protein expression, and showed no reported safety concerns.", "population_specificity": "Stage 3-5 CKD patients (56% males; mean age 68.20 years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:28.827906+00:00"}
{"study_id": 2110, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) could mitigate rhabdomyolysis-induced acute kidney injury by inhibiting macrophage M1 polarization and suppressing the cGAS-STING pathway.", "results_summary": "APS significantly reduced UREA and CREA levels, inhibited M1 macrophage infiltration, decreased inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1), and exhibited anti-apoptotic effects on podocytes. These effects were consistent in both in vivo and in vitro experiments.", "population_specificity": "C57BL/6J mice and raw264.7 macrophage cell line.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:30.856473+00:00"}
{"study_id": 2111, "supplement_id": 897, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the safety, stability, and antitumor efficacy of a novel astragalus polysaccharide-based nano-delivery system (MTX-PPT-micelles) for targeted ovarian cancer therapy.", "results_summary": "The MTX-PPT-micelles demonstrated good stability, safety, and slow drug release, significantly enhancing tumor uptake, apoptosis, and inhibition of proliferation, invasion, and metastasis. They also improved tumor immunosuppression by polarizing macrophages from M2 to M1 phenotype.", "population_specificity": "Ovarian cancer cells and mouse models (ectopic tumor and lung metastasis).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:31.422832+00:00"}
{"study_id": 2113, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the cardioprotective effects of Astragalus polysaccharide (APS) on radiation-induced heart disease (RIHD) and its underlying molecular mechanisms.", "results_summary": "APS improved cardiac dysfunction, reduced myocardial injury and fibrosis, alleviated apoptosis and atrophy in H9C2 cells, and reversed autophagy flux accumulation by modulating the PI3K/Akt/mTOR pathway. The study identified key genes and pathways involved in APS's protective effects against RIHD.", "population_specificity": "Rats with radiation-induced heart disease and H9C2 cells exposed to ionizing radiation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:33.165686+00:00"}
{"study_id": 2112, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether the combination of Astragalus membranaceus and Carthamus tinctorius (HQ-HH) could mitigate cerebral ischemia/reperfusion injury (CI/RI) by regulating PARP-1/TAX1BP1-mediated Complex I activity and inhibiting parthanatos.", "results_summary": "HQ-HH improved behavioral function and reduced cerebral infarction in rats, inhibited PARP-1 activity, decreased ROS production, and suppressed nuclear translocation of AIF, ultimately antagonizing parthanatos. The treatment showed dose-dependent neuroprotective effects in both animal and cell models.", "population_specificity": "Rats with middle cerebral artery occlusion/reperfusion (MCAO/R) and BV2 cells subjected to oxygen glucose deprivation/reoxygenation (OGD/R).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:34.039557+00:00"}
{"study_id": 2114, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) could alleviate mammary inflammation, oxidative stress, and restore blood-milk barrier integrity in response to Staphylococcus aureus infection, while also exploring its role in modulating gut microbiota.", "results_summary": "APS effectively mitigated S. aureus infection in murine mammary glands, reduced inflammation and oxidative stress, restored blood-milk barrier integrity, and enriched Ruminococcus bromii in the gut, which facilitated beneficial short-chain fatty acid metabolism.", "population_specificity": "Murine (mice) model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:34.368091+00:00"}
{"study_id": 2115, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the mechanism and causal relationship between Astragalus polysaccharides (APS) and gut microbiota in treating ulcerative colitis (UC).", "results_summary": "APS improved colonic injury, restored gut microbiota balance, and enhanced intestinal immune homeostasis in mice with colitis. Its efficacy depended on gut microbiota, as it was ineffective in antibiotic-treated mice but effective when combined with fecal microbiota transplantation (FMT).", "population_specificity": "Mice with DSS-induced colitis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:36.650456+00:00"}
{"study_id": 2117, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) could regulate gut microbiota and short-chain fatty acids (SCFAs) to slow the progression of chronic kidney disease (CKD) in mice.", "results_summary": "APS supplementation reduced serum creatinine and urea nitrogen levels, attenuated renal injury and fibrosis, upregulated SCFA-producing bacteria, increased SCFA levels, and enhanced kidney G protein-coupled receptor (GPR) levels in adenine-induced CKD mice.", "population_specificity": "Adenine-induced chronic kidney disease (CKD) mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:36.856540+00:00"}
{"study_id": 2116, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the effects of Astragalus polysaccharide (APS) on gut microbiota and serum metabolites in asthmatic mice, and its potential to improve airway inflammation and hyperreactivity.", "results_summary": "APS improved airway inflammation and eosinophil infiltration in asthmatic mice, corrected gut microbial imbalance by reducing Firmicutes and increasing Bacteroidetes, and influenced serum metabolites, particularly in unsaturated fatty acid and pyrimidine metabolism pathways.", "population_specificity": "BALB/c female mice with OVA-induced asthma.", "effective_dosage": "2.5 g/kg, 5.0 g/kg, and 10 g/kg APS, administered intragastrically 1 hour prior to each OVA stimulation.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:37.557621+00:00"}
{"study_id": 2119, "supplement_id": 897, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Astragalus polysaccharide (APS) combined with GS chemotherapy in treating pancreatic cancer, focusing on immune function and long-term survival.", "results_summary": "APS combined with GS improved objective response rates, disease control rates, immune function (higher CD3+ and CD4+ T cells), reduced adverse reactions (leukopenia, thrombocytopenia, fatigue), and extended median survival time compared to GS alone.", "population_specificity": "97 patients diagnosed with pancreatic cancer receiving GS chemotherapy.", "effective_dosage": "Not specified", "study_duration": "4 cycles of treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:39.527363+00:00"}
{"study_id": 2118, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the drought tolerance and compensatory capacity of dark septate endophytes (DSEs), including their effects on plant root growth under drought and rehydration conditions.", "results_summary": "The study found that M. pseudophaseolina and S. lupini significantly enhanced root weight (20.36% and 23.82%, respectively) after rehydration following drought stress, with lipid and amino acid metabolites playing key roles in drought tolerance.", "population_specificity": "Plants (specific species not mentioned in the abstract) inoculated with DSEs under drought and rehydration conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:39.809917+00:00"}
{"study_id": 2120, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the effects of Astragalus polysaccharide (APS) on cerebral ischemia-reperfusion injury and its mechanisms, focusing on microglial polarization and O-GlcNAcylation.", "results_summary": "APS reduced pro-inflammatory cytokines (IL-1\u03b2, IL-6) and increased anti-inflammatory IL-10, promoted M2 microglial polarization, and enhanced OGT-mediated O-GlcNAcylation, alleviating cerebral I/R injury in both cell and rat models.", "population_specificity": "Middle cerebral artery occlusion (MCAO)-treated rats and oxygen glucose deprivation/reoxygenation (OGD/R)-treated BV2 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.097062+00:00"}
{"study_id": 2121, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of astragalus polysaccharide (APS) on diabetic retinopathy via the SHH-Gli1-AQP1 pathway in a type 2 diabetes mellitus (T2DM) model.", "results_summary": "APS and metformin significantly mitigated retinal damage in STZ-induced T2DM rats by suppressing the overactivated SHH-Gli1-AQP1 signaling pathway, reducing elevated expression levels of SHH, Gli1, and AQP1.", "population_specificity": "STZ-induced T2DM rats", "effective_dosage": "Varying doses (specific amounts not stated)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:42.678189+00:00"}
{"study_id": 2123, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Astragaloside IV (AS) from Astragalus membranaceus could improve cognitive impairment and neuroinflammation induced by chronic stress, and whether these effects were mediated by specific gut microbiota.", "results_summary": "AS improved cognitive impairment, reduced neuroinflammation, and restored intestinal barrier damage in stressed mice, with these effects dependent on the presence of gut microbiota, particularly Lactobacillus reuteri.", "population_specificity": "Mice subjected to chronic unpredictable mild stress (CUMS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:45.033128+00:00"}
{"study_id": 2124, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effect of formononetin (FMN) from Astragalus membranaceus on chronic renal failure (CRF) and elucidate its underlying mechanism.", "results_summary": "FMN improved renal function, reduced fibrosis markers, inhibited inflammatory cytokines, and suppressed the PI3K/Akt signaling pathway in both in vivo and in vitro models.", "population_specificity": "Adenine-induced CRF rats and TGF-\u03b21-stimulated human proximal tubule epithelial cells (HK-2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:45.058563+00:00"}
{"study_id": 2125, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify the key active components of Astragalus membranaceus and determine their effective targets in colorectal cancer (CRC) patients.", "results_summary": "The study identified 20 active components of Astragalus and 86 differentially expressed target genes in CRC, with significant enrichment in biological processes and pathways. Molecular docking confirmed interactions between active components (quercetin and formic acid) and key biomarkers.", "population_specificity": "Colorectal cancer (CRC) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:45.585137+00:00"}
{"study_id": 2127, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the regulatory roles of Astragalus-derived compounds and extracts on breast cancer cell proliferation, migration, invasion, and chemoresistance, as well as its synergistic effects with chemotherapeutic agents.", "results_summary": "The study found that Astragalus demonstrates potential in inhibiting breast cancer cell proliferation, migration, and invasion, and shows synergistic effects with chemotherapy by enhancing chemosensitivity, reducing toxic side effects, and reversing drug resistance. It suggests promise for integrated treatment approaches combining traditional and modern medicine.", "population_specificity": "Breast cancer (in vitro and/or in vivo studies, specific human population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effects with chemotherapeutic agents mentioned, but no specific interactions with foods or other supplements noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:49.515809+00:00"}
{"study_id": 2126, "supplement_id": 897, "safety_score": "80", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether Astragalus polysaccharides (PG2) could reduce chemotherapy-induced fatigue and toxicity in breast cancer patients undergoing adjuvant chemotherapy.", "results_summary": "The study found no significant difference in fatigue scores between PG2 and placebo groups overall, but premenopausal patients in the PG2 group showed less aggravation of fatigue and improved global health status. PG2 also reduced insomnia and negative effects on future perspectives in this subgroup.", "population_specificity": "Patients with stage II/III early breast cancer planning to undergo adjuvant anthracycline-based chemotherapy, particularly premenopausal women.", "effective_dosage": "500 mg on days 1, 3, and 8 every 21 days.", "study_duration": "First four cycles of adjuvant chemotherapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:50.337355+00:00"}
{"study_id": 2128, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to study the mechanism of action of Astragalus and its active ingredients in the intervention of gastrointestinal tumors and propose a new approach for research from the perspective of medicine and food homology.", "results_summary": "The study found that Astragalus polysaccharides, saponins, and flavonoids have antitumor effects and suggested Astragalus as a potential complementary therapy for gastrointestinal tumors. The research highlighted its role in tumor treatment but did not provide specific clinical outcomes.", "population_specificity": "Not specified (general focus on gastrointestinal tumors).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:51.519072+00:00"}
{"study_id": 2129, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Astragalus total flavone (AS-TF) and Astragalus calycosin (AS-CA) on growth performance, intestinal immunity, and microflora in weaned piglets.", "results_summary": "AS-TF and AS-CA improved growth performance, reduced diarrhea rates, enhanced serum and intestinal immunity, and positively influenced intestinal microbial composition, with AS-CA showing superior effects in some areas.", "population_specificity": "Weaned piglets", "effective_dosage": "AS-TF at 60 mg/day per piglet; AS-CA at 30 mg/day per piglet", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:52.876104+00:00"}
{"study_id": 2130, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of combined pellets (CPs) containing Astragalus components (TAS and APS) to treat renal fibrosis in a UUO-induced model and assess their effects on gut microbiota modulation.", "results_summary": "The CPs improved the dissolution of Astragalus components, delivered them effectively to target sites, ameliorated kidney pathology, reduced collagen deposition, decreased inflammatory cytokines, and restored gut microbiota balance in UUO rats.", "population_specificity": "UUO-induced renal fibrosis model in rats.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:54.258826+00:00"}
{"study_id": 2131, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether isoliquiritigenin (ISL) derived from Astragalus could enhance radiotherapy sensitivity in lung cancer and attenuate radiation-induced bystander effects in bone marrow mesenchymal stem cells (BMSCs).", "results_summary": "The study found that ISL combined with carbon ion radiotherapy had a significant anti-tumor effect and protected BMSCs from radiation damage, suggesting potential as a radiosensitizer.", "population_specificity": "C57BL/6 mouse lung cancer transplantation tumor model (in vivo) and co-culture model of A549 cells and BMSCs (in vitro).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:54.599869+00:00"}
{"study_id": 2132, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To investigate the effects of astragalus polysaccharide (APS) on aplastic anaemia (AA) in mice and explore its mechanisms via the Hippo pathway.", "results_summary": "APS treatment increased peripheral blood cell counts, restored bone marrow haematopoietic function, reduced adipocyte infiltration, and elevated expression of TERT and Hippo pathway effectors (LATS 1/2, YAP, TEAD) in AA mice.", "population_specificity": "BALB/c mice with induced aplastic anaemia.", "effective_dosage": "200 mg/kg (low), 400 mg/kg (medium), 800 mg/kg (high), administered via continuous gavage.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:55.082326+00:00"}
{"study_id": 2133, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharides (APS) could modulate the crosstalk between inflamed microglia and astrocytes in multiple sclerosis (MS) via the Sema4D-PlexinB2 signaling pathway.", "results_summary": "APS alleviated neurological dysfunction in EAE mice, inhibited the formation of pro-inflammatory microglia and astrocytes, and suppressed inflammatory factors and neurotoxicity. APS also blocked the Sema4D-PlexinB2 signaling pathway, which is critical for MIMS-AIMS crosstalk.", "population_specificity": "Experimental autoimmune encephalomyelitis (EAE) mice (an MS model) and in vitro co-cultures of microglia and astrocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:53:59.230407+00:00"}
{"study_id": 2134, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to investigate the effects of a herbal complex containing Astragalus (CAA) on muscle fatigue and endurance capacity in patients with chronic fatigue symptoms.", "results_summary": "The CAA group showed significant improvements in fatigue severity, exercise endurance, and oxygen consumption compared to the placebo group, suggesting Astragalus-containing supplements may help treat chronic fatigue.", "population_specificity": "80 patients with chronic fatigue symptoms (ages ~41-44).", "effective_dosage": "Not specified (study used a mixture of Cervus elaphus, Angelica gigas, and Astragalus membranaceus).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:00.610072+00:00"}
{"study_id": 2135, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharides (APS) protect the blood-brain barrier (BBB) in experimental autoimmune encephalomyelitis (EAE) mice and explore the potential mechanism involving endothelial-to-mesenchymal transition (EndoMT) and ETS1 regulation.", "results_summary": "APS reduced BBB leakage in EAE mice by inhibiting EndoMT and upregulated ETS1 expression, which played a central role in maintaining BBB integrity. In vitro, APS also prevented IL-1\u03b2-induced EndoMT and endothelial dysfunction in brain endothelial cells.", "population_specificity": "Experimental autoimmune encephalomyelitis (EAE) mice and mouse brain endothelial cells (bEnd.3).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:02.492265+00:00"}
{"study_id": 2139, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the immunomodulatory effects of Astragalus polysaccharide (APS) in obese mice and its potential for obesity prevention.", "results_summary": "APS showed dose-dependent effects, with a 4% concentration significantly reducing body weight and improving blood glucose and lipid profiles, while a 2% concentration tended to increase weight. APS also reactivated suppressed immune function in obese mice.", "population_specificity": "Diet-induced obese (DIO) mice", "effective_dosage": "2% and 4% concentrations of APS", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.319001+00:00"}
{"study_id": 2136, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy and mechanism of Astragalus membranaceus-Pueraria lobata decoction (AP) in treating chemotherapy-induced intestinal mucositis (CIM).", "results_summary": "AP supplementation significantly alleviated CPT-11-induced body injury in Drosophila, improving survival, digestion, movement, reproduction, and developmental processes. It also repaired intestinal atrophy, improved acid-base homeostasis, and inhibited immune-related Toll and Imd pathways while enhancing antioxidant capacity.", "population_specificity": "Drosophila (fruit flies) model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.423217+00:00"}
{"study_id": 2138, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the neuroprotective potential of Astragalus polysaccharide (APS) in a model of NMDA-induced retinal neurodegeneration, exploring its potential as a treatment for retinal degenerative diseases.", "results_summary": "APS treatment protected retinal cells, mitigated NMDA-induced apoptosis, and attenuated the reduction in retinal ganglion cell projections to visual centers, suggesting neuroprotective effects via inhibition of the NF-\u03baB signaling pathway.", "population_specificity": "Model of NMDA-induced retinal neurodegeneration (animal study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.424589+00:00"}
{"study_id": 2137, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the impact of Astragalus membranaceus extract (combined with Codonopsis pilosula) on growth performance, immune function, antioxidant capacity, gut microbiota, and short-chain fatty acids in weaned piglets.", "results_summary": "The study found that the Astragalus extract improved growth performance, reduced diarrhea rates, enhanced immune function and antioxidant capacity, increased beneficial gut bacteria, and elevated short-chain fatty acid levels in weaned piglets.", "population_specificity": "Weaned piglets (31-day-old)", "effective_dosage": "0.5% (LCA), 1.0% (MCA), and 1.5% (HCA) of the diet", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:03.777405+00:00"}
{"study_id": 2140, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how Trichoderma harzianum induces defense responses in Astragalus mongholicus against Fusarium solani infection.", "results_summary": "The study found that Trichoderma harzianum upregulated resistance-related pathways and genes (e.g., PR1, formononetin, biochanin A) in Astragalus mongholicus, enhancing its defense against Fusarium solani. H2O2 content increased, and key compounds like formononetin and biochanin A showed potential to suppress the pathogen.", "population_specificity": "Astragalus mongholicus (plant roots)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:08.375275+00:00"}
{"study_id": 2141, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the pharmacological effects and molecular mechanism of Astragalus membranaceus (AM) in treating ischemic heart failure (IHF) using network pharmacology, molecular docking, and in vitro experiments.", "results_summary": "The study identified core active components (e.g., quercetin, kaempferol) and targets (e.g., AKT1, IL6) of AM, demonstrating strong binding affinity and activation of the PI3K-AKT pathway. In vitro experiments showed AM enhanced cell viability, reduced heart failure biomarkers, and suppressed apoptosis.", "population_specificity": "In vitro experimental model (not specified if human or animal cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:10.225423+00:00"}
{"study_id": 2143, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective effect and mechanism of Astragalus polysaccharide (APS) on autoimmune encephalomyelitis in mice.", "results_summary": "APS significantly reduced the incidence and severity of autoimmune encephalomyelitis, delayed disease onset, reduced myelin loss, improved inflammatory response, and activated the AMPK/JAK/STAT3/Arginase-1 signaling pathway.", "population_specificity": "C57BL/6 mice with induced Experimental Autoimmune Encephalomyelitis (EAE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.242677+00:00"}
{"study_id": 2142, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining Astragalus polysaccharides (APS) with tumor cell lysates in a nanovaccine could enhance anti-tumor immune responses in colorectal cancer.", "results_summary": "The nanovaccine (NP-TCL@APS) promoted dendritic cell activation, enhanced CD8+ T cell responses, and suppressed tumor growth in mouse models, demonstrating improved anti-tumor efficacy.", "population_specificity": "Colorectal cancer tumor-bearing mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:11.373312+00:00"}
{"study_id": 2144, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) could enhance the persistence and antitumoral efficacy of CD8+ CAR-T cells, particularly by promoting memory T cell formation and migration in hepatocellular carcinoma models.", "results_summary": "APS significantly improved the persistence of CAR-T cells and enhanced their tumor suppression in xenograft models. It increased CD122+/CXCR3+ memory T cells, reduced PD-1+ subsets, and promoted STAT5 phosphorylation, enhancing CAR-T cell migration and antitumoral effects.", "population_specificity": "Human cancer cell lines (Huh7 and HepG2) and tumor-bearing mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:12.156242+00:00"}
{"study_id": 2145, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the molecular mechanism of Astragalus membranaceus (AM) and its monomer, Calycosin, in alleviating peritoneal fibrosis (PF) and related muscle atrophy via the AR/TGF-\u03b21 pathway.", "results_summary": "AM was found to regulate the AR/TGF-\u03b21 signaling pathway, alleviating PF and muscle atrophy in CKD-PF mice. Calycosin, a monomer of AM, partially reversed mesothelial mesenchymal transition via the same pathway.", "population_specificity": "CKD-PF mice models and HMrSV5 cells.", "effective_dosage": "High- and low-dose AM (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.178041+00:00"}
{"study_id": 2146, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which astragalus polysaccharide (APS) reduces CD8+T cell infiltration in neuroinflammatory models and its protective effects on brain endothelial cells.", "results_summary": "APS reduced CD8+T cell infiltration in neuroinflammatory models by downregulating vascular cell adhesion molecule1 and upregulating zonula occludens-1 and vascular endothelial cadherin, enhancing brain endothelial barrier function. The PI3K/AKT pathway mediated this protective effect.", "population_specificity": "Experimental autoimmune encephalomyelitis mice and LPS-induced neuroinflammatory models, including mouse brain endothelial cells (bEnd.3).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:13.450753+00:00"}
{"study_id": 2147, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) could effectively treat Brucella melitensis infection in mice by reducing bacterial load and modulating immune responses.", "results_summary": "APS treatment reduced bacterial load, alleviated splenomegaly, lowered pro-inflammatory cytokines (CXCL1, IFN-\u03b3, IL-1\u03b2, IL-2, IL-12p70, TNF-\u03b1), increased IL-4 levels, and shifted macrophage ratios from M2 to M1 in infected mice.", "population_specificity": "Mice infected with Brucella melitensis M5.", "effective_dosage": "Not specified (intraperitoneal injection daily).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:17.589954+00:00"}
{"study_id": 2148, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the immunomodulatory, anti-inflammatory, and anti-allergic potential of Astragalus membranaceus in alleviating allergy symptoms.", "results_summary": "The study confirmed Astragalus's efficacy in in vivo and clinical studies for immunomodulatory and anti-allergic effects but highlighted issues with phytochemical characterization and dose variability. More standardized clinical trials are needed.", "population_specificity": "Not specified (general allergy sufferers implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.308909+00:00"}
{"study_id": 2149, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antitumor effects of Astragalus polysaccharides (APS) on lung adenocarcinoma A549 cells, including its potential synergistic effects with metformin.", "results_summary": "APS reduced the growth of lung cancer cells and showed a synergistic effect with metformin, suggesting promise as a combination therapy for lung adenocarcinoma.", "population_specificity": "Lung adenocarcinoma A549 cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Synergistic effect with metformin noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.706648+00:00"}
{"study_id": 2150, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) inhibits melanoma stem cell induction and overcomes tumor immune evasion by down-regulating PD-L1 expression.", "results_summary": "APS reduced tumor sphere formation and CSC marker expression, inhibited PD-L1 expression, and increased CD4+ and CD8+ T cell infiltration in melanoma tissues, suggesting potential therapeutic benefits.", "population_specificity": "Melanoma stem cells (MSCs) and melanoma mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:18.963976+00:00"}
{"study_id": 2151, "supplement_id": 897, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of astragalus injection (AI) on left ventricular remodeling (LVR) in patients with heart failure with mildly reduced ejection fraction (HFmrEF).", "results_summary": "The meta-analysis found that AI significantly improved LVR, clinical efficacy, and reduced NT-pro BNP levels without increasing adverse reactions compared to conventional treatment. Sensitivity analysis confirmed reliability, and no significant publication bias was detected.", "population_specificity": "Patients with heart failure with mildly reduced ejection fraction (HFmrEF) (995 participants: 562 males, 433 females).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:21.286657+00:00"}
{"study_id": 2153, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the neuroprotective and anti-Parkinson effects of various fractions of Astragalus grahamianus, focusing on its antioxidant potential and bioactive constituents.", "results_summary": "The study found that Astragalus grahamianus fractions contain diverse bioactive compounds, with the methanol fraction (AGME) showing the highest antioxidant activity and significant neuroprotective effects in an in-vivo rat model. The correlation between antioxidant activity and total phenolic content was substantial.", "population_specificity": "In-vivo rat model (specific human population not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.622618+00:00"}
{"study_id": 2152, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to summarize the molecular mechanisms and therapeutic effects of Astragalus polysaccharides (APS) in treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.", "results_summary": "APS demonstrated significant neuroprotective effects, including improving insulin resistance, reducing blood glucose levels, enhancing cognitive function, reducing A\u03b2 accumulation, protecting neurons, stabilizing mitochondrial function, and promoting myelin regeneration through various pathways. The study highlighted APS's antioxidant, anti-inflammatory, immunomodulatory, and neuroprotective properties.", "population_specificity": "Not specified (review of molecular mechanisms and therapeutic effects, not a clinical trial).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:22.652654+00:00"}
{"study_id": 2154, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how Astragalus polysaccharides (APS) enhance intestinal barrier function by modulating gut microbiota and related metabolic pathways.", "results_summary": "APS improved intestinal barrier function in broiler chickens by thickening the mucus layer, reducing crypt depth, and promoting tight junction proteins. It selectively increased beneficial bacteria (Parabacteroides distasonis and Bacteroides uniformis) and elevated isobutyrate and bile acid concentrations, activating key signaling pathways.", "population_specificity": "Broiler chickens", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:25.940143+00:00"}
{"study_id": 2155, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the molecular mechanisms and synergistic effects of the Astragalus-Coptis drug pair in treating diabetic kidney disease (DKD).", "results_summary": "The study identified 27 active ingredients and 512 potential targets of the Astragalus-Coptis pair, with quercetin showing high affinity for key targets like AKT1 and TNF, suggesting its role in modulating pathways related to DKD. The findings indicate multi-target, multi-pathway therapeutic effects.", "population_specificity": "Diabetic kidney disease (DKD) patients (in silico and database analysis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:27.192533+00:00"}
{"study_id": 2156, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanism of Astragalus aqueous extract in healing diabetic foot ulcers via the HIF-1\u0251/VEGF signaling pathway in a rat model.", "results_summary": "Astragalus extract significantly accelerated ulcer healing compared to controls, upregulated HIF-1\u0251 and VEGF expression, and reduced IL-6 and CRP levels, suggesting improved tissue repair and reduced inflammation.", "population_specificity": "Diabetic male Sprague Dawley rats with induced foot ulcers.", "effective_dosage": "Not specified (wet gauze with Astragalus extract applied daily).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:27.509145+00:00"}
{"study_id": 2157, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review recent advancements and applications of Astragalus membranaceus in NSCLC treatment, focusing on its pharmacological properties and potential integration into existing therapies.", "results_summary": "The abstract highlights Astragalus membranaceus's broad pharmacological properties, including immune regulation, anti-inflammatory effects, and modulation of ROS and enzyme activities, suggesting potential benefits for NSCLC treatment. However, it calls for further research on molecular mechanisms, dosage optimization, and safety evaluation alongside standard therapies.", "population_specificity": "Non-small cell lung cancer (NSCLC) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:27.583446+00:00"}
{"study_id": 2158, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify the active ingredients of Astragalus (HUANGQI), its potential targets, and mechanisms of action in treating Alzheimer's disease (AD).", "results_summary": "The study found that Astragalus contains 12 active ingredients with 679 common targets linked to AD, and it demonstrated protective effects against A\u03b21-42-induced neuronal cell damage in a dose-dependent manner. The mechanisms involve TNF, AGE, NF-\u03baB pathway, and nuclear receptor activity-related processes.", "population_specificity": "HT-22 cells (a mouse hippocampal neuronal cell line) exposed to A\u03b21-42.", "effective_dosage": "0-240 \u03bcg/mL (effective concentration EC50 = 83.46 \u03bcg/mL).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:30.804054+00:00"}
{"study_id": 2160, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to uncover the metabolic reprogramming effects of Astragalus membranaceus and Carthamus tinctorius (AC) on cerebral ischemia/reperfusion injury (CIRI) at systemic and microregional levels and elucidate its therapeutic mechanisms.", "results_summary": "AC significantly reduced neurological damage, minimized infarct size, and repaired blood-brain barrier damage in CIRI rats. It reversed metabolic imbalances in key brain regions and systemic circulation, involving 14 metabolic pathways.", "population_specificity": "Rats with cerebral ischemia/reperfusion injury (CIRI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.145153+00:00"}
{"study_id": 2159, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether HT042 (a standardized functional food ingredient containing Astragalus) could recover dexamethasone-induced growth retardation in children by activating specific signaling pathways and enhancing receptor expression.", "results_summary": "HT042 activated the Indian hedgehog/parathyroid hormone-related protein pathway, increased growth hormone and insulin-like growth factor-1 receptors, restored growth plate length, promoted cell proliferation, and demonstrated anti-apoptotic effects in both ex vivo and in vitro models.", "population_specificity": "Pediatric patients requiring long-term dexamethasone treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:31.399066+00:00"}
{"study_id": 2161, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how Astragalus Polysaccharide (APS) enhances the antithrombotic efficacy of Puerarin (PUE) by improving its plasma exposure and bioavailability.", "results_summary": "APS improved PUE's water solubility, intestinal absorption, and oral bioavailability, enhancing its antithrombotic effect by suppressing the HMGB1/NF-\u03baB/NLRP3 pathway. The combination of Astragalus and Puerariae Radix (HGD) showed synergistic effects in thrombosis treatment.", "population_specificity": "Mice (thrombosis model) and rats (pharmacokinetic study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:34.821042+00:00"}
{"study_id": 111989, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent advances in plant polysaccharides, including Astragalus, as autophagy modulators for treating metabolic syndrome.", "results_summary": "The study suggests that Astragalus polysaccharides, among other plant-derived polysaccharides, regulate autophagy and may alleviate metabolic syndrome, though specific efficacy data for Astragalus alone are not detailed.", "population_specificity": "General population affected by metabolic syndrome (no specific subgroup mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:35.065353+00:00"}
{"study_id": 111991, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the kidney-protective effects of botanicals with medicine-food homology, including Astragalus, focusing on their antioxidative and anti-inflammatory properties.", "results_summary": "The study highlights that Astragalus and similar botanicals contain micronutrients like flavonoids and polysaccharides, which show powerful activities against renal diseases and potential benefits for the \"gut-kidney\" axis.", "population_specificity": "Not specified (general discussion of medicinal herbal food for kidney health).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:35.141124+00:00"}
{"study_id": 2162, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the therapeutic efficacy and mechanisms of Total Astragalus Saponins (TAS) in treating primary sclerosing cholangitis (PSC) using mouse models.", "results_summary": "TAS, particularly at 56 mg/kg, significantly improved liver injury, cholestasis, inflammation, and fibrosis in PSC mouse models by rescuing TGR5 expression and inhibiting NF-\u03baB p65 phosphorylation. The anti-PSC effects of TAS were dependent on TGR5 expression, as efficacy was lost in Tgr5-/- mice.", "population_specificity": "Mouse models of PSC (DDC-induced and Mdr2-/- spontaneous PSC) and Tgr5-/- mice.", "effective_dosage": "56 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:36.555933+00:00"}
{"study_id": 111995, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the clinical efficacy of Astragalus as part of the RPAB herbal combination for treating CPHD and to elucidate its mechanisms of action.", "results_summary": "The study found that Astragalus, combined with other herbs and Western medicine, improved blood gas analysis, pulmonary function, and reduced plasma viscosity in CPHD patients. It targeted multiple pathways, including chemokine and JAK-STAT signaling, to remodel pulmonary arteries and reduce inflammation and oxidative stress.", "population_specificity": "Middle-aged and older adults with Chronic Pulmonary Heart Disease (CPHD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:39.633650+00:00"}
{"study_id": 111997, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of Astragalus (specifically Astragaloside IV and Astragalus polysaccharides) as a therapeutic agent for cancer-induced cardiac cachexia (CICC) by examining its anti-inflammatory, antioxidant, and pro-survival effects.", "results_summary": "The study found that Astragalus components, particularly Astragaloside IV and Astragalus polysaccharides, show promise in improving heart injury associated with CICC by targeting pathological processes like inflammation and oxidative stress. Advanced drug delivery systems were also discussed as potential methods to enhance their therapeutic effects.", "population_specificity": "Patients with terminal cancer suffering from cancer-induced cardiac cachexia (CICC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:40.590123+00:00"}
{"study_id": 111994, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effective components of Astragali Radix for intestinal protection and explore its pharmacological effects and molecular mechanisms in treating various intestinal diseases.", "results_summary": "Astragali Radix and its active components demonstrated protective effects against intestinal diseases like colorectal cancer, inflammatory bowel disease, and enterocolitis through mechanisms such as anti-inflammatory actions, antioxidative stress responses, and modulation of intestinal microbiota. However, some pharmacological actions and mechanisms remain unexplored, and further toxicological and clinical studies are needed.", "population_specificity": "Not specified (general intestinal disease context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:40.867303+00:00"}
{"study_id": 111998, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review recent studies on the component composition and biological activities of various Astragalus species, focusing on their potential health benefits.", "results_summary": "The study found that Astragalus species, particularly A. membranaceus, contain bioactive compounds with anti-inflammatory, immunomodulatory, antioxidant, anticancer, cardioprotective, and hepatoprotective effects, though other species remain understudied.", "population_specificity": "Not specified (in vitro and in vivo studies referenced, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:42.534682+00:00"}
{"study_id": 112000, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the mechanisms of myelosuppression and evaluate the potential of natural products, including Astragalus, as therapeutic agents for ameliorating this condition.", "results_summary": "Astragalus, among other natural products, showed promising potential in ameliorating myelosuppression by modulating hematopoietic stem cells, immune factors, and critical signaling pathways. The study highlighted its role in immune response modulation and hematopoietic stimulation.", "population_specificity": "Cancer patients experiencing myelosuppression due to radiotherapy or chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.053921+00:00"}
{"study_id": 112002, "supplement_id": 897, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "To determine the efficacy and safety of Astragalus combined with RAAS blockers in treating stage III diabetic nephropathy.", "results_summary": "Astragalus combined with RAAS blockers significantly improved total effective rate and reduced urinary protein excretion, serum creatinine, blood urea nitrogen, and glycosylated hemoglobin levels. Subgroup analysis showed differential effects based on the type of RAAS blocker used.", "population_specificity": "Patients with stage III diabetic nephropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "RAAS blockers (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:43.430642+00:00"}
{"study_id": 112003, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess whether Astragalus could slow kidney function decline in diabetic CKD patients with macroalbuminuria when added to standard care.", "results_summary": "The study found that adding Astragalus to standard care for 48 weeks further stabilized kidney function in patients with type 2 diabetes, stage 2-3 CKD, and macroalbuminuria.", "population_specificity": "Patients with type 2 diabetes, stage 2-3 CKD (eGFR 30-90 ml/min/1.73m\u00b2), and macroalbuminuria.", "effective_dosage": "Not specified in the abstract.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:44.784387+00:00"}
{"study_id": 112004, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential anti-aging effects of Astragalus polysaccharide and other compounds, focusing on their mechanisms and screening using C. elegans.", "results_summary": "Astragalus polysaccharide was identified as one of the active ingredients from plants with potential anti-aging effects in preclinical and clinical studies, alongside other compounds like resveratrol and ginsenosides. The study highlighted the utility of C. elegans for evaluating anti-aging compounds efficiently.", "population_specificity": "Preclinical studies in C. elegans and related clinical trials in humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.036054+00:00"}
{"study_id": 112005, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of Astragalus in managing chronic constipation by regulating intestinal flora as part of traditional Chinese medicine adjunct therapy.", "results_summary": "The study highlighted Astragalus as one of the single Chinese herbs effective in treating chronic constipation by optimizing intestinal flora composition, though specific efficacy data were not detailed. It was grouped with other herbs and formulations showing promise in alleviating constipation symptoms.", "population_specificity": "Patients with chronic constipation seeking complementary therapies, particularly traditional Chinese medicine.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.457967+00:00"}
{"study_id": 112006, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize existing studies on the use of astragaloside IV, a component of Astragalus, for treating acute kidney injury (AKI).", "results_summary": "The abstract highlights that Astragalus, particularly astragaloside IV, is commonly used in traditional Chinese medicine for AKI treatment, but it does not provide specific efficacy results from the summarized studies.", "population_specificity": "Patients with acute kidney injury (AKI), particularly those in ICU settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.668881+00:00"}
{"study_id": 112008, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify the researchers' goal regarding Astragalus.", "results_summary": "The abstract does not provide results specific to Astragalus.", "population_specificity": "Not specified for Astragalus.", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:48.741743+00:00"}
{"study_id": 112007, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to systematically evaluate the efficacy of combining astragalus injection with ambroxol hydrochloride as an adjuvant treatment for COPD.", "results_summary": "The meta-analysis found that the combination of astragalus injection and ambroxol hydrochloride improved clinical parameters in COPD patients compared to conventional treatment alone, including a higher clinical effective rate (OR\u2009=\u20095.44, 95% CI 3.51-8.43).", "population_specificity": "1070 patients with chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:50.576969+00:00"}
{"study_id": 112009, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect of Astragalus on humoral and cellular immune response in human studies through a systematic review and meta-analysis.", "results_summary": "Astragalus significantly reduced proinflammatory cytokines (IL-2, IL-4, IL-6, IL-10, TNF-\u03b1, IFN-\u03b3) and enhanced cellular immune markers (CD3 levels, CD4/CD8 ratio), supporting its immunomodulatory effects. However, substantial heterogeneity was observed among studies.", "population_specificity": "1,094 human participants across 19 studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:52.258874+00:00"}
{"study_id": 112001, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the latest pharmacological effects of Astragalus Radix (AR) on diabetic nephropathy (DN) and explore its potential mechanisms of action.", "results_summary": "The study found that AR exhibits protective effects on DN through mechanisms such as anti-fibrosis, anti-inflammation, anti-oxidative stress, anti-podocyte apoptosis, and restoration of mitochondrial and endothelial function in experimental models. AR shows promise as a potential novel therapeutic for DN.", "population_specificity": "Diabetic nephropathy experimental models (not specified if human or animal).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:53.135697+00:00"}
{"study_id": 112010, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent pharmacological advances in using Astragaloside IV (AS-IV) from Astragalus membranaceus for treating cardiovascular diseases (CVDs).", "results_summary": "The study highlights that AS-IV shows promising results in treating CVDs, with fewer side effects and higher therapeutic efficiency compared to conventional treatments. It emphasizes AS-IV's potential in addressing inflammatory, oxidative stress, and metabolic disorders in cardiomyocytes.", "population_specificity": "Not specified (general CVD context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:54.125894+00:00"}
{"study_id": 112013, "supplement_id": 897, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of Astragalus injection (HQI) combined with traditional symptomatic treatment (TST) compared to TST alone in treating neonatal hypoxic-ischemic encephalopathy (HIE).", "results_summary": "The study found that HQI + TST significantly improved treatment performance compared to TST alone, though it did not specify Astragalus's individual outcomes. No obvious adverse drug reactions were reported.", "population_specificity": "Neonatal patients with hypoxic-ischemic encephalopathy (HIE).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:56.698474+00:00"}
{"study_id": 112011, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether combining Astragalus membranaceus and Rhizoma Dioscoreae with Western medicine improves efficacy against diabetic nephropathy compared to Western medicine alone.", "results_summary": "The combination significantly reduced 24-hour urinary protein levels in diabetic nephropathy patients, with effects observed regardless of treatment duration (\u22644 weeks or >4 weeks). The reduction was statistically significant and not time-dependent.", "population_specificity": "Patients with diabetic nephropathy (diabetic kidney disease).", "effective_dosage": "Not specified", "study_duration": "Varied (\u22644 weeks or >4 weeks subgroups)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.203594+00:00"}
{"study_id": 112014, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent studies on Astragali Radix and its formulations in treating type 2 diabetes mellitus by modulating the intestinal microbiota.", "results_summary": "Astragalus components (polysaccharides, saponins, flavonoids) showed promising effects in reducing insulin resistance, promoting islet cell proliferation, suppressing \u03b2 cell death, and improving glucose and lipid metabolism. The study highlights Astragalus's potential in managing diabetes through gut microbiota modulation.", "population_specificity": "Not specified (general focus on type 2 diabetes mellitus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:57.299223+00:00"}
{"study_id": 112012, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the biological activity and clinical applications of Ezhu (Curcumae Rhizoma) herb pairs, including its combination with Astragalus (Huangqi), and analyze their compatibility effects.", "results_summary": "The study found that Ezhu and Astragali Radix (Huangqi) are commonly used in clinical treatment of tumors, particularly digestive tract-related inflammation, liver cancer, and gynecological tumors, with a positive dose correlation. The combination showed efficacy in activating blood circulation and treating related disorders.", "population_specificity": "Not specified (clinical applications and traditional use referenced).", "effective_dosage": "Not specified (dose correlation noted but exact amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:58.587237+00:00"}
{"study_id": 112017, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "To evaluate the efficacy and safety of combined traditional Chinese medicine, including Astragalus, as adjuvant therapy for proliferative diabetic retinopathy (PDR).", "results_summary": "Meta-analysis of 18 studies showed that traditional Chinese medicine adjuvant therapy, including Astragalus, significantly improved clinical effectiveness (OR=2.99), but more high-quality trials are needed to confirm safety and efficacy.", "population_specificity": "Patients with proliferative diabetic retinopathy (PDR).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:54:59.900324+00:00"}
{"study_id": 112018, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms by which Astragaloside IV (AS-IV) improves diabetic kidney disease (DKD) and facilitate related pharmacological research.", "results_summary": "The study found that AS-IV improves DKD by combating oxidative stress, attenuating endoplasmic reticulum stress, regulating calcium homeostasis, alleviating inflammation, improving vascular function, and reducing epithelial to mesenchymal transition. It highlights AS-IV as a promising novel drug for DKD treatment.", "population_specificity": "Patients with diabetic kidney disease (DKD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:00.959040+00:00"}
{"study_id": 112019, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of Astragalus membranaceus combined with supportive care or immunosuppressive therapy in treating moderate-high risk idiopathic membranous nephropathy (IMN).", "results_summary": "The meta-analysis found that Astragalus combined with supportive care or immunosuppressive therapy significantly improved 24-hour urinary total protein, serum albumin, serum creatinine levels, and remission rates compared to standard therapies alone. The results were statistically significant and clinically meaningful.", "population_specificity": "Patients with moderate-high risk idiopathic membranous nephropathy (IMN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:02.013178+00:00"}
{"study_id": 112020, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the chemical components and mechanisms of Astragalus mongholicus Bunge in treating myocardial fibrosis (MF) and evaluate its potential as a therapeutic candidate.", "results_summary": "Astragalus mongholicus Bunge and its active components, such as Astragaloside IV and Astragalus polysaccharide, showed potential benefits against MF by regulating inflammation, oxidative stress, and pro-fibrotic signaling pathways. However, further research is needed to confirm unverified mechanisms and assess side effects.", "population_specificity": "Not specified (primarily preclinical or experimental studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:04.398603+00:00"}
{"study_id": 112015, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify the researchers' goals regarding Astragalus.", "results_summary": "The abstract does not provide results related to Astragalus.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.396208+00:00"}
{"study_id": 112022, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the mechanism of action of Astragalus membranaceus in treating peritoneal metastasis and assess its potential as a therapeutic option.", "results_summary": "The study found that Astragalus membranaceus contains bioactive components (polysaccharides, saponins, flavonoids) that may help prevent peritoneal metastasis by maintaining peritoneal integrity, restoring immune balance, and inhibiting tumor-related processes. However, clinical evidence is limited, and findings from prior studies are inconsistent.", "population_specificity": "Patients with cancer, particularly those at risk of or experiencing peritoneal metastasis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:05.811562+00:00"}
{"study_id": 112021, "supplement_id": 897, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of a dietary supplement containing Astragalus (as part of the DAPAD complex) for treating uncomplicated acute E. coli UTIs in nonmenopausal women.", "results_summary": "The DAPAD complex, which included Astragalus, showed significantly higher clinical and bacteriological resolution rates compared to placebo, with no severe adverse events attributed to the supplement.", "population_specificity": "Nonmenopausal women with acute uncomplicated E. coli UTIs.", "effective_dosage": "The DAPAD complex was administered twice a day (specific Astragalus dosage not detailed).", "study_duration": "5 days of intervention, with follow-up until day 35.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:06.239824+00:00"}
{"study_id": 112023, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the mechanism of action, pharmacokinetics, and drug optimization research progress of astragaloside IV in the treatment of atopic diseases.", "results_summary": "The study found that astragaloside IV, a main active ingredient in Astragalus membranaceus, has good antiallergic and immunomodulatory effects, making it potentially useful for treating atopic diseases. The paper summarizes its therapeutic mechanisms and research advancements.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.229910+00:00"}
{"study_id": 112024, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effectiveness and advantages of QM granules, which include Astragalus, in treating diabetic retinopathy through traditional application analysis, network pharmacology, and clinical research.", "results_summary": "The study found that QM granules, containing Astragalus, effectively treat diabetic retinopathy through multiple components, targets, and pathways, supported by traditional pharmacological analysis, network pharmacology, animal experiments, and clinical studies.", "population_specificity": "Patients with diabetic retinopathy.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:07.592805+00:00"}
{"study_id": 112025, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Astragalus; it focuses on fucoidan as a marine-derived anticancer agent.", "results_summary": "The abstract does not discuss Astragalus; it highlights fucoidan's anticancer properties, including cell cycle arrest, apoptosis induction, and metastasis inhibition.", "population_specificity": "Not specified (abstract does not mention Astragalus).", "effective_dosage": "Not mentioned (abstract does not mention Astragalus).", "study_duration": "Not mentioned (abstract does not mention Astragalus).", "interactions": "None mentioned (abstract does not mention Astragalus).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:08.730373+00:00"}
{"study_id": 112026, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the antitumor effects of Astragalus polysaccharide (APS) and its mechanism of modulating dendritic cells (DCs) in tumor immunotherapy.", "results_summary": "The study found that APS promotes DC maturation by enhancing the expression of surface molecules CD80 and CD86, activates cytotoxic T lymphocytes (CTLs), and exerts antitumor effects. The review suggests APS could provide new strategies for tumor therapy and drug development.", "population_specificity": "Not specified (likely in vitro or animal models, based on abstract context).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:09.961493+00:00"}
{"study_id": 112027, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the therapeutic effect and mechanism of Astragalus injection on viral myocarditis, focusing on its influence on inflammatory mediators and overall treatment efficiency.", "results_summary": "The meta-analysis found that Astragalus injection significantly reduced pro-inflammatory TNF-\u03b1 levels and improved overall treatment efficiency in viral myocarditis patients, though results were treated cautiously due to significant heterogeneity among studies.", "population_specificity": "Patients with viral myocarditis (all studies conducted in China).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:12.000936+00:00"}
{"study_id": 112030, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the bidirectional effects and underlying mechanisms of Astragalus membranaceus, particularly its regulation of blood pressure and immune function.", "results_summary": "The study found that Astragalus exhibits bidirectional regulation of blood pressure and immune function, aligning with traditional Chinese medicine principles. The effects were attributed to factors like dosage, processing, and patient physiological conditions.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.593205+00:00"}
{"study_id": 112028, "supplement_id": 897, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the efficacy and safety of Chinese medicinal preparations containing astragalus in the prevention and treatment of radiation-induced lung injury (RILI).", "results_summary": "The study found that astragalus-containing prescriptions significantly reduced the total incidence of RILI, improved treatment effectiveness and cure rates, enhanced patient quality of life, alleviated breathing difficulties, and reduced inflammatory factors, with no reported adverse reactions.", "population_specificity": "Patients with radiation-induced lung injury (1762 participants across 25 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:13.717446+00:00"}
{"study_id": 112032, "supplement_id": 897, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze the efficacy of Astragalus membranaceus and its chemical components in treating multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).", "results_summary": "The study found that Astragalus membranaceus has multiple therapeutic effects, including immune modulation, antioxidative, anti-tumor, and anti-inflammatory properties, with relatively fewer adverse reactions. It showed promise in treating MS/EAE by addressing immune dysfunction and CNS inflammation.", "population_specificity": "Patients with multiple sclerosis (MS) and experimental models of autoimmune encephalomyelitis (EAE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:14.942445+00:00"}
{"study_id": 112029, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether astragalus polysaccharide could prevent cardiotoxicity induced by epirubicin chemotherapy in breast cancer and malignant lymphoma patients.", "results_summary": "Astragalus polysaccharide significantly reduced cardiotoxicity incidence (15% vs. 60%) and improved cardiac function markers (LVEF, E/A, cTnI, CK-MB) at 6-month follow-up compared to the control group, though no significant differences were observed in TNF-\u03b1, GPx, or SOD levels.", "population_specificity": "248 patients with breast cancer or malignant lymphoma undergoing epirubicin chemotherapy.", "effective_dosage": "Not specified (astragalus injection used).", "study_duration": "Intervention spanned at least two chemotherapy courses, with follow-up at 6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:15.017943+00:00"}
{"study_id": 112033, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review preclinical and clinical research on traditional Chinese medicines, including Astragalus, for their potential in delaying aging and treating neurodegenerative diseases like Alzheimer's.", "results_summary": "The abstract highlights that natural compounds like Astragalus show multitargeting potential in neuroprotection and could be promising for developing novel Alzheimer's treatments, though specific results for Astragalus are not detailed.", "population_specificity": "Not specified (general review of preclinical and clinical studies)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:15.584595+00:00"}
{"study_id": 112034, "supplement_id": 897, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "To evaluate the effect of Kangai injection (containing Astragalus) combined with platinum-based chemotherapy on clinical efficacy, immune function, and toxicity reduction in advanced non-small-cell lung cancer (NSCLC) patients.", "results_summary": "The combination of Kangai injection (including Astragalus) with platinum-based chemotherapy significantly improved objective response rate, disease control rate, Karnofsky performance status, and immune function while reducing chemotherapy-induced toxicity (e.g., white blood cell toxicity, platelet toxicity, and vomiting).", "population_specificity": "Patients with stage III-IV non-small-cell lung cancer (NSCLC).", "effective_dosage": "Not specified (Kangai injection dosage not detailed in abstract).", "study_duration": "Not specified (duration of intervention not detailed in abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:18.206946+00:00"}
{"study_id": 112035, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify the key active ingredients and potential pharmacological mechanisms of Astragalus membranaceus (AM) in treating diabetic nephropathy (DN) using network pharmacology.", "results_summary": "The study identified 17 active ingredients and 214 target proteins from AM, with 61 co-expressed genes linked to DN treatment. Key pathways involved inflammatory response, angiogenesis, and oxidative stress, with VEGFA, EGFR, STAT1, and GJA1 identified as hub genes. The study also revealed miRNA regulation by these hub genes, suggesting a multi-target, multi-pathway mechanism for AM in DN treatment.", "population_specificity": "Diabetic nephropathy patients (specific demographics not detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:18.832076+00:00"}
{"study_id": 112036, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the pharmacodynamic properties and pharmaceutical research on Astragalus polysaccharides (APs) to support their clinical application by elucidating therapeutic mechanisms and bioavailability improvements.", "results_summary": "APs show therapeutic potential for multiple diseases, including nervous system, cardiovascular, diabetes, and cancer, but low bioavailability limits clinical use. Nanocrystals and structural modifications enhance bioavailability, potentially expanding applications.", "population_specificity": "Not specified (cell and animal experiments referenced, clinical application mentioned but not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:19.824297+00:00"}
{"study_id": 112038, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the antitumor activities and mechanisms of polysaccharides from Astragalus and other Asian food sources, focusing on their potential as non-toxic alternatives or adjuvants to traditional cancer treatments.", "results_summary": "The study highlighted that Astragalus polysaccharides exhibit antitumor and immunopotentiating activities with minimal side effects, suggesting potential applications in cancer therapy or as adjuvant treatments. However, fewer studies exist on Astragalus compared to other sources like mushrooms.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:21.773497+00:00"}
{"study_id": 112040, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the potential of Chinese herbal medicines, including Astragalus, in addressing pathogenic factors of Parkinson's disease.", "results_summary": "The abstract does not provide specific findings about Astragalus, only mentioning a summary of 32 Chinese herbal medicines.", "population_specificity": "Not specified (general review of Parkinson's disease research).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:21.876171+00:00"}
{"study_id": 112037, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of Astragalus polysaccharide (APS) as a vaccine adjuvant by analyzing its immunomodulatory effects and safety profile.", "results_summary": "The study found that Astragalus polysaccharide (APS) exhibits good immune-promoting effects, enhancing humoral, cellular, and mucosal immunity, with low toxicity and high biocompatibility. It suggests APS could be a viable adjuvant for clinical vaccine use if mechanisms are further studied.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.066778+00:00"}
{"study_id": 112039, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroregenerative potential of complementary and alternative medicines (CAMs), including Astragalus, for peripheral nerve injury recovery.", "results_summary": "The study reviewed existing literature on CAMs, including Astragalus, and highlighted their potential for peripheral nerve regeneration, though specific findings on Astragalus were not detailed in the abstract.", "population_specificity": "Not specified (general focus on peripheral nerve injury).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:22.117935+00:00"}
{"study_id": 112041, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to assess the anti-inflammatory and anti-microbial effects of Astragalus sarcocolla, among other medicinal plants, for treating acne vulgaris based on Traditional Persian Medicine references.", "results_summary": "The study found that Astragalus sarcocolla, along with other plants, demonstrated both anti-inflammatory and anti-microbial mechanisms, suggesting potential therapeutic benefits for acne vulgaris.", "population_specificity": "Not specified (review of traditional texts and recent literature).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:23.220940+00:00"}
{"study_id": 112043, "supplement_id": 897, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the efficacy and safety of Aidi injection (containing Astragalus) in combination with gemcitabine-based chemotherapy for advanced non-small cell lung cancer.", "results_summary": "Aidi injection plus gemcitabine-based chemotherapy significantly improved objective response rate, disease control rate, and quality of life while reducing the risk of various adverse drug reactions compared to chemotherapy alone. The evidence quality ranged from moderate to low.", "population_specificity": "4318 patients with advanced non-small cell lung cancer.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.543448+00:00"}
{"study_id": 112042, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the adjuvant beneficial effects of Aidi injection (containing Astragalus) on cancer survival, tumor responses, quality of life, and reduction of chemo/radiotherapy side effects.", "results_summary": "Aidi injection showed additional beneficial effects on survival, objective response rate, quality of life, and reduction of side-effects from chemo/radiotherapy, primarily in lung, liver, and colorectal cancer patients. However, methodological and reporting quality of the included systematic reviews were weak.", "population_specificity": "Cancer patients (lung, liver, colorectal, gastric, lymphoma, breast, esophageal, ovary, and mixed cancers).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:26.613311+00:00"}
{"study_id": 112044, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Astragalus membranaceus's potential in cancer therapy, focusing on its immune-modulating effects and ability to mitigate chemotherapy-induced toxicity.", "results_summary": "Astragalus demonstrated immune-modulating properties, reduced chemotherapy-induced toxic effects, and showed potential anti-cancer activity through its phytoconstituents like formononetin, astragalus polysaccharide, and astragalosides. It also helped alleviate cancer-related fatigue in clinical trials.", "population_specificity": "Cancer patients undergoing chemotherapy (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:27.511334+00:00"}
{"study_id": 112047, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the chemical differences between two Astragalus species and summarize the pharmacological activities and mechanisms of action of Huang-Qi for treating cardiovascular diseases.", "results_summary": "The study identified 189 small molecules from Astragalus species, highlighting interspecies chemical differences, and summarized the cardiovascular protective effects and mechanisms of Huang-Qi and its bioactive compounds.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.170589+00:00"}
{"study_id": 112046, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the main components, mechanisms, and clinical applications of ZL capsule (containing Astragalus) for cardiovascular and cerebrovascular diseases.", "results_summary": "The study found that ZL capsule, including Astragalus, exhibited anti-inflammatory, anti-apoptotic, and angiogenesis-promoting effects in treating cardiovascular and cerebrovascular diseases through multi-component, multi-target, and multi-pathway mechanisms. Over 1000 clinical cases benefited from the treatment, supporting its efficacy.", "population_specificity": "Patients with cardiovascular and cerebrovascular diseases (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.476874+00:00"}
{"study_id": 112048, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Astragalus as an add-on therapy for diabetic kidney disease (DKD) by assessing changes in kidney function and other biomarkers.", "results_summary": "The study is ongoing, but it aims to measure changes in estimated glomerular filtration rate, urine albumin-to-creatinine ratio, and other secondary endpoints like fasting blood glucose and adverse events. Results will be analyzed using regression models, but final outcomes are not yet reported.", "population_specificity": "118 patients diagnosed with diabetic kidney disease (DKD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:29.780201+00:00"}
{"study_id": 112049, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of nutritional interventions, including Astragalus polysaccharide, in regulating skeletal muscle insulin sensitivity.", "results_summary": "The study found that Astragalus polysaccharide, among other natural phytochemicals, has been shown to protect skeletal muscle cells, mice, or humans from insulin resistance. The evidence suggests it may facilitate glucose utilization and regulate protein turnover in skeletal muscle.", "population_specificity": "Skeletal muscle cells, rodents, nonhuman primates, and humans (with or without diabetes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:31.021339+00:00"}
{"study_id": 112045, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the regulatory effects of traditional Chinese medicine (TCM), including Astragalus, on cancer cell metabolic reprogramming and its potential as an antitumor agent.", "results_summary": "The study found that TCM, including Astragalus, can modulate cancer cell metabolism by targeting metabolic enzymes and signaling pathways, potentially impeding cancer progression and acting as chemosensitizers. Multiple targets and pathways were identified, highlighting TCM's poly-pharmacological advantages in cancer therapy.", "population_specificity": "Cancer cells (in vitro or preclinical models, not specified for Astragalus specifically).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:31.465269+00:00"}
{"study_id": 112050, "supplement_id": 897, "safety_score": "85", "efficacy_score": 78, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the cardiovascular protective potential of calycosin, a bioactive flavonoid in Astragalus, focusing on its effects on cardiac myocytes and vascular endothelial cells.", "results_summary": "Calycosin demonstrated multiple beneficial effects, including antioxidant, pro-angiogenesis, and anti-inflammatory properties, which contributed to cardiovascular protection by reducing cardiac myocyte damage and promoting vascular endothelial cell function. The study highlighted its potential in treating conditions like arrhythmia, myocardial ischemia, and angina.", "population_specificity": "Not specified (in vitro and in vivo studies referenced, but no specific human population detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.836201+00:00"}
{"study_id": 112052, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy, safety, and mechanisms of Astragalus membranaceus (AM) for treating viral myocarditis (VM) through clinical and preclinical systematic reviews.", "results_summary": "AM significantly reduced serum myocardial enzymes and cardiac troponin I levels and improved clinical treatment efficiency in VM patients compared to the control group. The study included 28 clinical trials and 16 animal studies, indicating consistent positive effects.", "population_specificity": "Patients with viral myocarditis (2522 participants in clinical studies) and animal models (634 animals in preclinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:34.844677+00:00"}
{"study_id": 112053, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effectiveness of Chinese Herbal Medicine (CHM), including Astragalus, for treating spinal cord injury (SCI) through a meta-analysis of randomized controlled trials.", "results_summary": "The study found significant improvements in ASIA-grading improvement rate, clinical effective rate, ASIA motor and sensory scores, and activities of daily living (ADL) scores in the CHM group compared to the control group. Buyang Huanwu decoction, which includes Astragalus, was the most frequently prescribed herbal formula.", "population_specificity": "Patients with spinal cord injury (1961 participants across 26 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:35.963295+00:00"}
{"study_id": 112055, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of traditional Chinese medicine, including Astragalus, as an alternative therapy for cardiovascular diseases.", "results_summary": "The abstract does not provide specific findings about Astragalus's effects, only highlighting the broader interest in natural active ingredients for CVD treatment.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:36.478482+00:00"}
{"study_id": 112054, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically analyze and summarize existing research on Fufang Xueshuantong Capsule (FXC), including Astragalus, focusing on quality control, pharmacokinetics, and pharmacological properties.", "results_summary": "The review found that FXC, containing Astragalus, has significant effects on fundus, cardiovascular, and cerebrovascular occlusive diseases, but noted gaps in quality control, pharmacokinetic studies, and mechanistic research.", "population_specificity": "Not specified (broad clinical applications implied)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:36.848915+00:00"}
{"study_id": 112056, "supplement_id": 897, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the maximum tolerated dose of SH003 (containing Astragalus) combined with docetaxel in patients with lung or breast cancer.", "results_summary": "The study found SH003 alone up to 4800 mg daily was safe, and preclinical studies suggested a synergistic effect with anticancer drugs. The maximum tolerated dose of SH003 combined with docetaxel was being investigated using a dose-escalation design.", "population_specificity": "Patients with lung or breast cancer.", "effective_dosage": "2400, 3600, and 4800 mg daily, taken orally.", "study_duration": "21 days.", "interactions": "Docetaxel (anticancer drug).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:38.400101+00:00"}
{"study_id": 112059, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to review the immunomodulatory effects of Astragalus and its potential application in treating immune-related diseases.", "results_summary": "The study found that Astragalus enhances immune function by promoting immune organ development, mucosal immunity, innate immunity (phagocytic capacity), and acquired immunity (cell maturation, antibody expression). It suggests Astragalus as a potential therapeutic intervention for immune-related diseases.", "population_specificity": "Not specified (preclinical and clinical studies reviewed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:38.828720+00:00"}
{"study_id": 112058, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the regulatory effects of traditional Chinese medicine, including Astragalus, on the Th17/Treg axis imbalance and its potential mechanisms in immune-mediated inflammatory diseases.", "results_summary": "The study found that Astragalus and other TCM herbs modulate the Th17/Treg axis, influencing immune balance, but specific efficacy data for Astragalus alone were not detailed. Frequency analysis of TCM prescriptions indicated common use in clinical trials.", "population_specificity": "Patients with immune-mediated inflammatory diseases (IMID)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:39.017641+00:00"}
{"study_id": 112061, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of different Chinese herbal injections, including Astragalus polysaccharide injection, when combined with TACE for treating liver cancer.", "results_summary": "Astragalus polysaccharide injection plus TACE showed superiority in clinical effective rate and performance status compared to other Chinese herbal injections, but its safety profile was not specifically addressed.", "population_specificity": "Patients with liver cancer (7,683 patients across 105 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:42.330799+00:00"}
{"study_id": 112062, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review recent progress on Astragaloside IV (AS-IV) in heart failure (HF) and provide potential evidence for its clinical application.", "results_summary": "The study found that AS-IV could protect against myocardial ischemia and regulate sarcoplasmic reticulum Ca, suggesting potential benefits for chronic heart failure (CHF) patients.", "population_specificity": "Patients with chronic heart failure (CHF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.050026+00:00"}
{"study_id": 112060, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate Astragalus membranaceus (AM) as an adjunctive therapy in cancer treatment, focusing on its anti-tumor effects, immune modulation, and potential to reduce chemotherapy side effects.", "results_summary": "AM was found to shrink or stabilize tumors through anti-proliferation and pro-apoptosis effects, enhance anti-tumor efficacy when combined with chemotherapy, and improve systemic immunity to potentially prevent metastasis. It also activated immune cells in the tumor microenvironment.", "population_specificity": "Cancer patients and various cancer models/cell lines (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:43.345124+00:00"}
{"study_id": 112064, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review recent experimental studies on the effects of Astragalus polysaccharides in treating diabetes mellitus and its complications.", "results_summary": "The study found that Astragalus polysaccharides showed promising effects in treating diabetes mellitus, including improvements in insulin resistance and secretion, as well as potential benefits for diabetic complications like neuropathy, retinopathy, cardiomyopathy, foot ulcers, and infections.", "population_specificity": "Not specified (review of experimental studies, likely involving animal models and/or human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:44.851274+00:00"}
{"study_id": 112065, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of astragaloside IV (from Astragalus) combined with tanshinone IIA on myocardial ischemic injury and inflammatory markers in patients with coronary heart disease.", "results_summary": "The study assessed multiple inflammatory markers and clinical symptoms but did not report specific results for Astragalus alone. The abstract indicates the trial is expected to provide valuable clinical evidence for CHD management.", "population_specificity": "160 patients with coronary heart disease.", "effective_dosage": "Not specified (treatment administered every 24 hours).", "study_duration": "7 days of treatment, followed by 28 days of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:45.603939+00:00"}
{"study_id": 112066, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to systematically summarize the pharmacological effects, pharmacokinetics, and toxicity of Astragaloside IV (AS-IV), focusing on its neuroprotective, liver-protective, anti-cancer, and anti-diabetic properties.", "results_summary": "The study found that AS-IV exhibits potent protective effects in cardiovascular, lung, kidney, and brain tissues, attributed to its antioxidant, anti-inflammatory, and anti-apoptotic properties. It also enhances immunity, reduces cancer cell migration and invasion, and improves chemosensitivity, acting through multiple signaling pathways.", "population_specificity": "Cellular and animal models (not specified for human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:46.536969+00:00"}
{"study_id": 112067, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review existing data on the effects of Astragalus membranaceus and other medicinal plants on male gonads, focusing on mechanisms like antioxidant, anti-inflammatory, and spermatogenesis-inducing properties.", "results_summary": "The abstract indicates that Astragalus membranaceus, among other plants, has demonstrated mechanisms of action in laboratory animals, in vitro, and human studies, including antioxidant, anti-inflammatory, and spermatogenesis-inducing effects. However, clinical application efforts remain limited.", "population_specificity": "Laboratory animals, in vitro studies, and human studies (unspecified demographics).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:47.387727+00:00"}
{"study_id": 112068, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of PG2 (Astragalus polysaccharides) injection on adverse events and quality of life in patients with advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiotherapy.", "results_summary": "The study found that PG2 injection reduced severe treatment-associated adverse events and improved quality of life (particularly in pain, appetite loss, and social eating behavior) compared to placebo, though it did not affect tumor response or survival outcomes.", "population_specificity": "Patients with advanced pharyngeal or laryngeal head and neck squamous cell carcinoma undergoing concurrent chemoradiotherapy.", "effective_dosage": "PG2 injection administered three times per week (sterile powder form).", "study_duration": "Duration of concurrent chemoradiotherapy (specific length not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:47.950081+00:00"}
{"study_id": 112069, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the mechanism of immune cells in liver fibrosis and the regulatory effects of Astragalus membranaceus and its active components on immune cells.", "results_summary": "The study suggests that Astragalus membranaceus and its active components may modulate immune cells to influence hepatic fibrosis and liver cirrhosis, offering potential therapeutic insights.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:49.173876+00:00"}
{"study_id": 112070, "supplement_id": 897, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy of Astragalus membranaceus (Huangqi) as an adjuvant therapy for managing post-stroke fatigue and improving quality of life.", "results_summary": "The study found that Astragalus reduced fatigue severity and improved quality of life in stroke patients, with mild adverse effects. However, the evidence was of poor quality due to high or unclear risks of bias in the included trials.", "population_specificity": "Post-stroke patients experiencing fatigue (total of 1222 participants across 16 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.219371+00:00"}
{"study_id": 112071, "supplement_id": 897, "safety_score": "70", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Astragalus membranaceus preparations as an adjunctive therapy to conventional treatments for diabetic kidney disease (DKD).", "results_summary": "The meta-analysis suggested that Astragalus injections, when added to conventional therapies, reduced albuminuria, proteinuria, and serum creatinine in DKD patients, though the evidence quality was low due to methodological limitations and heterogeneity.", "population_specificity": "Diabetic kidney disease (DKD) patients (4,785 participants across 66 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:51.927479+00:00"}
{"study_id": 112073, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effects of Astragalus membranaceus extracts on autophagy dysregulation-associated diseases.", "results_summary": "The study found that Astragalus extracts exhibit biological activities related to autophagy, including anti-oxidation, anti-inflammation, anticancer, anti-photoaging, and improvement of cardiomyocyte function, suggesting therapeutic potential for autophagy-related diseases.", "population_specificity": "Not specified (literature review).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:52.354646+00:00"}
{"study_id": 112074, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of saponins, including those from Astragalus, on intestinal inflammation and related digestive diseases.", "results_summary": "The study found that saponins, including those from Astragalus, can suppress intestinal inflammation, promote barrier repair, maintain gut flora diversity, and reduce colon-inflammation-related cancer incidence.", "population_specificity": "Animal models (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:54.757715+00:00"}
{"study_id": 112075, "supplement_id": 897, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the benefits of Astragalus injection (AGI) as an adjuvant to platinum-based chemotherapy in advanced nonsmall cell lung cancer (NSCLC) patients.", "results_summary": "AGI combined with chemotherapy improved objective response rate, Karnofsky performance status, 1-year survival rate, and immune markers (CD3, CD4, CD4/CD8, NK cells) while reducing leukopenia, platelet toxicity, and vomiting. However, the evidence quality was rated as low.", "population_specificity": "Advanced nonsmall cell lung cancer (NSCLC) patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:55.846039+00:00"}
{"study_id": 112076, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the current research status of JQJTT (which includes Astragalus) for diabetes treatment, identify existing problems, and propose future research directions.", "results_summary": "The study found that JQJTT, containing Astragalus, is effective for diabetes but highlighted issues like incomplete quality control, unclear pharmacological mechanisms, and the need for clinical reevaluation. Future research directions include improving quality assessment and exploring interactions with gut microbiota and pharmacokinetics.", "population_specificity": "Patients with diabetes (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:56.246482+00:00"}
{"study_id": 112077, "supplement_id": 897, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to confirm whether Aidi injection (containing Astragalus) improves tumor responses and survival in NSCLC patients, while assessing its safety, optimal usage, and combination with paclitaxel.", "results_summary": "Aidi injection plus paclitaxel-based chemotherapy significantly improved clinical efficacy, quality of life, and reduced adverse reactions like hematotoxicity, gastrointestinal toxicity, and liver injury in NSCLC patients. Optimal usage was suggested as 50 ml/time and 14 days/2 cycles.", "population_specificity": "Patients with stage III/IV non-small cell lung cancer (NSCLC).", "effective_dosage": "50 ml/time, 80 ml/time, or 100 ml/time; 14 days/2 cycles or 21 days/2-4 cycles.", "study_duration": "Varied by cycle (14 days/2 cycles or 21 days/2-4 cycles).", "interactions": "Paclitaxel-based chemotherapy (specifically TP regimen).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.507797+00:00"}
{"study_id": 112079, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of Astragaloside IV (AS-IV) in experimental models of neurological disorders.", "results_summary": "The study found that AS-IV improved motor deficits and neurochemical activity in models of Parkinson's disease, Alzheimer's disease, cerebral ischemia, and autoimmune encephalomyelitis, primarily through antioxidant, anti-inflammatory, and antiapoptotic mechanisms.", "population_specificity": "Experimental models (animal or in vitro studies) of neurological disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.584288+00:00"}
{"study_id": 112078, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of Danggui Buxue Tang (DBT) supplementation on exercise performance, hepcidin levels, iron status, and related biochemical parameters after intense aerobic exercise.", "results_summary": "DBT supplementation significantly improved running performance (14.0% faster finish times), repressed hepcidin levels post-exercise, and increased iron levels by 63.3% and 31.4% at different recovery points, but showed no significant anti-inflammatory or haemolysis-preventative effects.", "population_specificity": "36 recreationally active males, pair-matched based on aerobic capacities.", "effective_dosage": "Not specified in the abstract.", "study_duration": "11 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.690786+00:00"}
{"study_id": 112080, "supplement_id": 897, "safety_score": "70", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and tolerability of SH003, a novel herbal medicine containing Astragalus, in patients with solid cancers.", "results_summary": "The study assessed toxicity using CTCAE criteria and defined dose-limiting toxicities as grade 3 or higher adverse events, but efficacy results were not reported in the abstract.", "population_specificity": "Patients with solid cancers.", "effective_dosage": "One to four tablets of SH003, three times a day.", "study_duration": "3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:55:59.892975+00:00"}
{"study_id": 112081, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of Astragalus as an adjuvant in cancer treatment, focusing on its ability to enhance efficacy and reduce side effects of chemo-, radio-, or targeted-therapy.", "results_summary": "Astragalus was found to suppress tumor progression, increase sensitivity to conventional therapies, improve immune function, and lessen therapy-induced damage. It also showed benefits in reducing cancer-related fatigue, pain, and gastrointestinal side effects.", "population_specificity": "Cancer patients undergoing chemo-, radio-, or targeted-therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.048697+00:00"}
{"study_id": 112082, "supplement_id": 897, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Aidi injection (containing Astragalus) in combination with platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer (NSCLC).", "results_summary": "The study found that Aidi injection plus platinum-based chemotherapy improved disease control, response rates, survival rates, and quality of life while reducing severe toxicities compared to chemotherapy alone. The results were statistically significant and clinically meaningful.", "population_specificity": "Patients with stage IIIB/IV NSCLC (4,081 participants across 42 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.599529+00:00"}
{"study_id": 112083, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of different doses of Astragalus membranaceus (AM) on diastolic function in postmenopausal hypertensive women with metabolic syndrome (MetS).", "results_summary": "The study found that AM at 10 g/d significantly improved diastolic function markers (E', E/A, E'/A', E/E') compared to conventional treatment alone. Waist circumference and waist-to-hip ratio were identified as potential risk factors for left ventricular diastolic dysfunction (LVDD).", "population_specificity": "Postmenopausal hypertensive women with metabolic syndrome.", "effective_dosage": "5 g/d (AM Group 1) and 10 g/d (AM Group 2).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:04.977421+00:00"}
{"study_id": 112072, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Astragalus (Huangqi) preparation in treating acute myocardial infarction (AMI) through a meta-analysis of randomized controlled trials.", "results_summary": "The study will provide evidence on Astragalus's effects on cardiac function (e.g., LVESV, LVEDV, LVEF), clinical outcomes (e.g., mortality, arrhythmias), and safety, but specific results are pending completion of the meta-analysis.", "population_specificity": "Patients with acute myocardial infarction (AMI).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:05.031636+00:00"}
{"study_id": 112084, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to describe radiological evaluations, classification systems, and biomechanical patterns involved in talar fractures, not Astragalus.", "results_summary": "The study did not investigate Astragalus; it focused on talar fractures, their complications, and treatment strategies.", "population_specificity": "Patients with talar fractures or traumatic talar dislocations.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:06.167977+00:00"}
{"study_id": 112085, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "To investigate the correlation between the clinical effects of Astragalus (Huangqi) on diabetic nephropathy (DN) and its pharmacological effects on macrophage iNOS activity.", "results_summary": "Meta-analysis and randomized controlled trials showed that Astragalus had therapeutic effects on different stages of DN and could regulate iNOS activity in macrophages, inducing nitric oxide (NO) production in resting macrophages and inhibiting it in activated macrophages.", "population_specificity": "Patients with diabetic nephropathy (stages III and III-IV) and macrophages in resting or activated states.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:07.502676+00:00"}
{"study_id": 112086, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of HT042 (containing Astragalus) on height growth in children with mild short stature.", "results_summary": "HT042 significantly increased height gain in children after 24 weeks, particularly in those below the 10th percentile, without advancing bone age. Serum IGF-1 and IGFBP-3 levels increased within the HT042 group, suggesting a potential mechanism for the observed effects.", "population_specificity": "Children aged 6-8 years with height below the 25th percentile.", "effective_dosage": "Not specified in the abstract.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:07.821991+00:00"}
{"study_id": 112087, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the immunoregulatory and anti-inflammatory effects of Astragaloside (ASI), a major component of Astragalus, and explore its potential mechanisms, including CD45 phosphatase activation and IFN-\u03b3 induction.", "results_summary": "The study found that ASI enhances CD45 phosphatase activity, regulates T-cell balance, inhibits pro-inflammatory cytokines and NF-\u03baB pathways, and may induce IFN-\u03b3 activity, supporting its traditional use in immune-related diseases.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:08.227403+00:00"}
{"study_id": 112088, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the cardioprotective effects of Astragalus polysaccharide against doxorubicin-induced cardiotoxicity in preclinical trials.", "results_summary": "The study found that Astragalus polysaccharide exhibited antioxidant properties and inhibited apoptosis, suggesting potential cardioprotective effects against doxorubicin-induced toxicity. Unlike synthetic agents, it did not impair the clinical activity of doxorubicin and was deemed safe for long-term use.", "population_specificity": "Preclinical trials (animal or in vitro models, not specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:11.842650+00:00"}
{"study_id": 112090, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects and mechanisms of Astragalus (as part of compound Chinese medicine) on microcirculatory dysfunction and organ injury following ischemia and reperfusion (I/R).", "results_summary": "The study found that Astragalus and other compound Chinese medicines exhibit protective and therapeutic effects against I/R-induced microcirculatory dysfunction and tissue injury, with mechanisms including energy metabolism regulation, antioxidant effects, and anti-inflammatory actions.", "population_specificity": "Not specified (general review of preclinical and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:12.600488+00:00"}
{"study_id": 112091, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the pharmacological actions and molecular mechanisms of Chinese herbs, including Astragalus, in lowering the risk and progression of diabetic retinopathy.", "results_summary": "The study found that Chinese herbs, including Astragalus, exhibit anti-inflammatory, antioxidant, anti-angiogenic, and other beneficial activities that counteract pathological conditions in the retina during diabetes, suggesting potential for treating or preventing diabetic retinopathy.", "population_specificity": "Diabetic retinopathy patients (implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:13.062738+00:00"}
{"study_id": 112092, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 1, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness and safety of oral Astragalus as a sole intervention for preventing frequent acute respiratory tract infections (ARTIs) in children.", "results_summary": "No randomized controlled trials (RCTs) met the inclusion criteria, so there was insufficient evidence to evaluate the effectiveness or safety of Astragalus for preventing ARTIs in children.", "population_specificity": "Children aged up to 14 years in community settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:13.587227+00:00"}
{"study_id": 112089, "supplement_id": 897, "safety_score": "80", "efficacy_score": 45, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effect of PG2, a polysaccharide extracted from Astragalus membranaceus, on patients with spontaneous acute intracerebral hemorrhage (ICH).", "results_summary": "The study found no significant differences in clinical outcomes (GOS and mRS scores) or inflammatory markers between the treatment and control groups, suggesting PG2 did not significantly improve outcomes in ICH patients. The results were preliminary, indicating a need for further assessment.", "population_specificity": "Patients with acute spontaneous intracerebral hemorrhage (61 participants, 30 in treatment group, 31 in control group).", "effective_dosage": "500 mg, IV, 3 doses per week for 2 weeks.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:13.754339+00:00"}
{"study_id": 112094, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to summarize existing data on the use of Chinese herbal medicine, including Astragalus, for promoting recovery in hematologic disorder patients undergoing hematopoietic stem cell transplantation.", "results_summary": "The study found Astragalus was commonly prescribed post-HSCT to promote engraftment, control graft-versus-host disease, and prolong survival, but the evidence was based on small, mostly retrospective studies with heterogeneous objectives.", "population_specificity": "Patients with hematologic disorders who received hematopoietic stem cell transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:15.293572+00:00"}
{"study_id": 112093, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Astragalus membranaceus (AM) on poststroke fatigue (PSF) in patients.", "results_summary": "AM significantly improved fatigue (BFI scores), cognitive functioning, social functioning, and global quality of life (QOL) compared to placebo, with statistically significant differences observed at multiple time points.", "population_specificity": "64 patients with poststroke fatigue (29 in treatment group, 32 in control group after attrition).", "effective_dosage": "2.8g three times per day.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:15.434077+00:00"}
{"study_id": 112095, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the pharmacological effects, metabolism mechanism, and toxicity of astragaloside IV (AS-IV), the main active substance of Astragalus membranaceus Bunge.", "results_summary": "AS-IV demonstrated multiple pharmacologic effects, including anti-inflammatory, antifibrotic, antioxidative stress, anti-asthma, antidiabetes, immunoregulation, and cardioprotective effects via various signaling pathways, with potential for broad clinical application.", "population_specificity": "Not specified (general pharmacological review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:15.939644+00:00"}
{"study_id": 112096, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the effects of Astragalus, in combination with other plant-based medicines, on reducing chemotherapy-induced neutropenia in colorectal cancer patients.", "results_summary": "Astragalus, when combined with other plant-based ingredients, was consistently associated with reduced incidence of grade 3/4 chemotherapy-induced neutropenia. No serious adverse events or reduction in tumor response rates were reported with its concurrent use alongside oxaliplatin.", "population_specificity": "Colorectal cancer patients undergoing chemotherapy (2224 participants across 32 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:19.755809+00:00"}
{"study_id": 112097, "supplement_id": 897, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects and safety of Kang'ai Xiaoshui ointment (containing Astragalus) in reducing malignant pleural effusion and alleviating associated symptoms.", "results_summary": "The treatment group showed a higher response rate (42.4% vs. 25.0%) and significant improvement in symptoms like chest distress, fullness, and shortness of breath, though some symptoms did not reach statistical significance. Adverse events, mainly skin irritation, were equally distributed between groups.", "population_specificity": "72 patients with malignant pleural effusion.", "effective_dosage": "Applied on the thorax wall for 8 hours daily (specific Astragalus dosage not detailed).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:21.859679+00:00"}
{"study_id": 112099, "supplement_id": 897, "safety_score": "85", "efficacy_score": 78, "quality_score": 65, "study_goal": "The researchers aimed to review the biological actions and signaling pathways of Astragalus polysaccharides in treating oxidative stress- and cancer-related diseases.", "results_summary": "The study found that Astragalus polysaccharides exhibit anti-oxidant, anti-inflammatory, immune-regulatory, and anti-tumor effects, primarily through ROS-centered and transcription factor-related pathways. These effects were observed in cell models, animal disease models, and clinical cases.", "population_specificity": "Not specified (general oxidative stress and cancer-related disease models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:21.911128+00:00"}
{"study_id": 112100, "supplement_id": 897, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to summarize the properties of Astragalus membranaceus and its major constituents, focusing on its immunomodulating, anti-inflammatory, and anticancer effects, particularly in gastrointestinal cancers.", "results_summary": "The study found that Astragalus and its saponin extract (AST) demonstrated significant immunomodulatory, anti-inflammatory, and anticancer effects, particularly in gastrointestinal cancers, by influencing immune responses and modulating cancer signaling pathways.", "population_specificity": "Not specified (general focus on experimental and clinical studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Mentioned interaction with immunosuppressants and cancer chemotherapeutics, reducing their toxicity.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:22.452420+00:00"}
{"study_id": 112098, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of Astragalus as an adjuvant treatment for type 2 diabetes mellitus (T2DM) through a meta-analysis of existing studies.", "results_summary": "Astragalus administration significantly reduced fasting plasma glucose (FPG) and postprandial plasma glucose (PPG) in both injection and aqueous decoction forms, with aqueous decoction also reducing fasting insulin (Fins) and HOMA-IRI levels. However, glycated hemoglobin A1c (HbA1c) reduction was only significant with aqueous decoction, not injection.", "population_specificity": "1054 participants with type 2 diabetes mellitus across 13 studies.", "effective_dosage": "Not specified (studies included Astragalus injection and aqueous decoction, but exact dosages not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:22.565933+00:00"}
{"study_id": 112102, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate whether combining Astragalus with oxaliplatin-based regimens improved tumor response rates in colorectal cancer patients.", "results_summary": "The study found that Astragalus, particularly in combination with Hedyotis and Scutellaria, contributed to higher tumor response rates in palliative CRC treatment. The effect was statistically significant and consistent across multiple trials.", "population_specificity": "Colorectal cancer patients in China or Japan receiving oxaliplatin-based chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:23.214077+00:00"}
{"study_id": 112103, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review recent findings on the chemistry and bioactivities of tetracyclic triterpenoids, including those from Astragalus membranaceus, particularly in relation to diabetes and its complications.", "results_summary": "The abstract highlights that tetracyclic triterpenoids, including those from Astragalus membranaceus, are widely distributed in medicinal plants used for diabetes treatment, but specific results regarding Astragalus's effects are not detailed.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:23.970579+00:00"}
{"study_id": 112101, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of Astragalus, among other traditional plant-based medicines, in reducing chemotherapy-induced nausea and vomiting (CINV) in patients receiving oxaliplatin-based regimens.", "results_summary": "The meta-analysis found that Astragalus, as part of an integrative approach, significantly reduced CINV compared to oxaliplatin controls, with mechanisms potentially involving gastrointestinal regulation and antioxidant effects. The study identified Astragalus as one of six plants associated with notable reductions in CINV without significant heterogeneity.", "population_specificity": "Patients with colorectal cancer undergoing oxaliplatin-based chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:24.243884+00:00"}
{"study_id": 112104, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the antidiabetic properties of Astragalus membranaceus and its bioactive compounds (polysaccharides, saponins, flavonoids) in treating diabetes mellitus and its complications.", "results_summary": "The study highlights Astragalus's potential antidiabetic effects, particularly its polysaccharides, saponins, and flavonoids, which show promise in addressing type 1 and type 2 diabetes through mechanisms like improving insulin resistance and glucose metabolism. However, specific clinical outcomes are not detailed in the abstract.", "population_specificity": "Not specified (general diabetes mellitus population, including type 1 and type 2).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:28.853696+00:00"}
{"study_id": 112106, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the therapeutic potential of natural compounds, including Astragalus, in suppressing keloid scar development by targeting signaling pathways involved in keloid formation.", "results_summary": "The study suggests that Astragalus, among other natural compounds, may suppress keloid scar development by modulating signaling pathways like TGF-\u03b21, MAPK, IGF-I, and integrin. However, specific efficacy data for Astragalus alone are not detailed.", "population_specificity": "Not specified (general review of keloid disorder mechanisms and potential treatments).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:29.991229+00:00"}
{"study_id": 112105, "supplement_id": 897, "safety_score": "80", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the benefits and potential harms of Astragalus for treating chronic kidney disease (CKD).", "results_summary": "Astragalus showed some promising effects, such as reducing proteinuria, increasing hemoglobin and serum albumin, and improving kidney function markers like CrCl and SCr, but results were inconsistent, and study quality was low. No adverse effects were reported in six studies, while the remaining 16 did not mention them.", "population_specificity": "People with chronic kidney disease (CKD), including 241 dialysis patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:30.430576+00:00"}
{"study_id": 112107, "supplement_id": 897, "safety_score": "80", "efficacy_score": 70, "quality_score": 50, "study_goal": "To assess the efficacy and safety of Astragalus membranaceus Injection combined with conventional therapy in the treatment of viral myocarditis.", "results_summary": "Astragalus membranaceus Injection combined with conventional treatment showed higher efficacy than conventional treatment alone, with significant improvements in myocardium enzyme levels and electrocardiography. However, the conclusion is limited by low methodological quality, small sample size, and high risk of bias.", "population_specificity": "639 participants with viral myocarditis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:30.903511+00:00"}
{"study_id": 112108, "supplement_id": 897, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical efficacy and safety of Astragalus polysaccharides injection combined with FOLFOX regimens versus FOLFOX alone in treating gastric cancer.", "results_summary": "The study found that Astragalus polysaccharides injection, when combined with FOLFOX, improved overall response rate, quality of life, and reduced nausea, vomiting, and leukopenia incidence compared to FOLFOX alone. It was ranked among the superior Chinese herb injections for gastric cancer treatment.", "population_specificity": "Patients with gastric cancer (2,761 participants across 38 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:31.597981+00:00"}
{"study_id": 112109, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Astragalus membranaceus could upregulate Cosmc expression and reverse IgA1 aberrant glycosylation in peripheral B lymphocytes of IgA nephropathy (IgAN) patients.", "results_summary": "Astragalus membranaceus injection (AMI) significantly upregulated Cosmc expression, decreased IgA1 secretion, and reversed aberrant glycosylation in a dose-related manner in IgAN patients' B lymphocytes. LPS-induced suppression of Cosmc and increased IgA1 secretion were counteracted by AMI.", "population_specificity": "21 IgAN patients and 10 normal controls.", "effective_dosage": "Not specified (dose-related effects noted but exact amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:32.584496+00:00"}
{"study_id": 112110, "supplement_id": 897, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the pharmacological effects, bioactive components, and safety profile of Semen Astragali Complanati (SAC) in treating chronic diseases.", "results_summary": "SAC contains fatty acids, amino acids, polysaccharides, flavonoids, and triterpene glycosides, with flavonoids being the main bioactive component. It exhibits therapeutic effects on chronic diseases like cardiovascular diseases, diabetes, and cancers, with low or non-existent toxicity.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:33.521875+00:00"}
{"study_id": 112111, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the \u03b1-glucosidase inhibitory effects of polysaccharides extracted from Astragalus compared to oyster mushroom and Yacon, to assess their potential as natural hypoglycemic agents.", "results_summary": "Astragalus polysaccharides showed the highest \u03b1-glucosidase inhibitory activity among the tested substances, with over 40% inhibition at 0.4 mg\u00b7mL(-1) and an IC50 of 0.28 mg\u00b7mL(-1). The results suggest Astragalus polysaccharides may be effective as a dietary supplement or therapeutic for diabetes.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "0.4 mg\u00b7mL(-1) (concentration used in testing)", "study_duration": "Not specified (single-time measurement)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:33.890735+00:00"}
{"study_id": 112112, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review recent reports on the potential effects and mechanisms of action of calycosin, a bioactive compound in Astragalus, for treating various diseases.", "results_summary": "The study found that calycosin shows promising effects in treating tumors, inflammation, stroke, and cardiovascular diseases, likely due to its isoflavonoid and phytoestrogenic properties, interacting with ER receptors and modulating the MAPK pathway.", "population_specificity": "Not specified (literature review of preclinical and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:38.062833+00:00"}
{"study_id": 112113, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to assess the clinical value of Huangqi injection (derived from Astragalus) in treating leucopenia through a meta-analysis of controlled trials.", "results_summary": "The meta-analysis found that Huangqi injection-treated patients showed greater therapeutic efficacy and lower white blood cell counts compared to control groups using Western medicine (P < 0.05), but the validity was limited by poor study quality.", "population_specificity": "841 patients with leucopenia across 13 studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:38.193329+00:00"}
{"study_id": 112114, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the clinical benefits of adding herbal medicines, including Astragalus, to FOLFOX4 chemotherapy for advanced colorectal cancer, focusing on tumor response, survival, quality of life, and adverse event reduction.", "results_summary": "The addition of Astragalus and other herbal medicines improved tumor response rate, one-year survival, and quality of life while reducing severe chemotherapy-related adverse events such as neutropenia, nausea, vomiting, and neurotoxicity.", "population_specificity": "Patients with advanced colorectal cancer receiving FOLFOX4 chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:39.281737+00:00"}
{"study_id": 112116, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize and analyze the anti-Parkinsonian activities of herbal medicines, including Astragalus, in PD models to provide future references for basic and clinical investigations.", "results_summary": "Astragalus was among the herbal medicines reported to be effective in PD models by modulating key events or signaling pathways implicated in PD pathogenesis. The study suggests Astragalus and other herbal medicines may be valuable candidates for further anti-Parkinsonian drug discovery.", "population_specificity": "PD models (in vitro and in vivo)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:40.495980+00:00"}
{"study_id": 112115, "supplement_id": 897, "safety_score": "80", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to assess the benefits and harms of herbal medicines, including Astragalus membranaceus, on clinical and indirect outcomes in patients with viral myocarditis.", "results_summary": "Astragalus membranaceus injection did not significantly reduce mortality but showed significant improvements in abnormal electrocardiogram results, ST-T changes, and reductions in creatine phosphate kinase (CPK) and lactate dehydrogenase (LDH) levels when combined with supportive therapy. However, the findings should be interpreted cautiously due to high risk of bias and limited trial quality.", "population_specificity": "Patients with viral myocarditis (acute and chronic) in China.", "effective_dosage": "Not specified", "study_duration": "Minimum of 7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:40.702162+00:00"}
{"study_id": 112119, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the mechanisms by which Astragalus may treat heart failure, focusing on myocardial contraction, cardiac cell protection, neuro-endocrine regulation, cytokine modulation, and left ventricular remodeling.", "results_summary": "The study found that Astragalus may improve heart failure through multiple mechanisms, including enhancing myocardial contraction, protecting cardiac cells, regulating neuro-endocrine systems, modulating cytokines, and inhibiting left ventricular remodeling.", "population_specificity": "Not specified (literature review of existing studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:41.900957+00:00"}
{"study_id": 112118, "supplement_id": 897, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to assess whether Astragalus (Huangqi granules) could effectively reduce the risk of infection in children with nephrotic syndrome.", "results_summary": "The study found that Huangqi granules significantly reduced the risk of infection in children with nephrotic syndrome (RR 0.62, 95% CI 0.47 to 0.83), with no serious adverse events reported. However, the methodological quality of the studies was poor, limiting the strength of the evidence.", "population_specificity": "Children with nephrotic syndrome in China.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:41.925046+00:00"}
{"study_id": 112117, "supplement_id": 897, "safety_score": "80", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to assess the effects of Astragalus membranaceus injection, in combination with supportive therapy, on clinical and indirect outcomes (e.g., electrocardiogram results, myocardial enzyme levels) in patients with viral myocarditis.", "results_summary": "The meta-analysis showed that Astragalus membranaceus injection plus supportive therapy significantly improved abnormal electrocardiogram results, ST-T changes, and reduced creatine phosphate kinase (CPK) and lactate dehydrogenase (LDH) levels. No serious adverse effects were reported, but data on adverse events were limited.", "population_specificity": "Patients with viral myocarditis (all trials were conducted in China).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Minimum of seven days (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:43.742220+00:00"}
{"study_id": 112121, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Astragalus polysaccharide (APS) combined with vinorelbine and cisplatin (VC) improved quality of life (QOL) and reduced chemotherapy toxicity in patients with advanced NSCLC compared to VC alone.", "results_summary": "The study found that APS combined with VC significantly improved QOL, physical function, and reduced chemotherapy-related side effects (fatigue, nausea, vomiting, pain, and loss of appetite) compared to VC alone, though it did not significantly improve tumor response or survival rates.", "population_specificity": "Patients with histologically or cytologically confirmed advanced non-small-cell lung cancer (NSCLC).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 cycles of treatment (duration per cycle not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:47.983280+00:00"}
{"study_id": 112122, "supplement_id": 897, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the angiogenic effect of astragaloside IV (a constituent of Astragalus) and its underlying mechanism in human umbilical vein endothelial cells (HUVECs) under hypoxia.", "results_summary": "Astragaloside IV promoted cell proliferation, stimulated HIF-1\u03b1 accumulation, activated the PI3K/Akt pathway, enhanced cell migration, increased tube formation, and promoted angiogenesis, with effects reversed by a PI3K inhibitor.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) under hypoxia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:48.263869+00:00"}
{"study_id": 112120, "supplement_id": 897, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of PG2, a partially purified extract of Astragalus membranaceus, as a complementary treatment for cancer-related fatigue (CRF) in advanced cancer patients.", "results_summary": "PG2 significantly improved CRF compared to placebo, with sustained benefits in most patients after two treatment cycles. Approximately 71% of non-responders in the first cycle showed improvement after the second cycle, and no major toxicities were observed.", "population_specificity": "Advanced cancer patients with moderate to severe cancer-related fatigue.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Two 4-week cycles (8 weeks total).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:48.693250+00:00"}
{"study_id": 114936, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness of bariatric surgery versus multidisciplinary programs for substantial and durable weight loss in obesity treatment.", "results_summary": "The study found that bariatric surgery achieved substantial and durable weight reduction, unlike conservative multidisciplinary programs, though the metabolic and pro-inflammatory benefits of post-surgery weight loss remain debated.", "population_specificity": "Individuals with obesity for whom conservative treatments have failed.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:56.859537+00:00"}
{"study_id": 114933, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of early bariatric surgery to improve outcomes in adolescents with severe, progressive type 2 diabetes.", "results_summary": "The abstract suggests that bariatric surgery has great potential to transform outcomes for adolescents with type 2 diabetes, though it remains controversial. The majority of adolescents rapidly progress to treatment failure with conventional therapies like metformin and insulin.", "population_specificity": "Adolescents with severe, progressive type 2 diabetes.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:56:57.062988+00:00"}
